WO2020009362A1 - Beet juice having increased intestinal absorption rate, preparation method therefor and use thereof - Google Patents

Beet juice having increased intestinal absorption rate, preparation method therefor and use thereof Download PDF

Info

Publication number
WO2020009362A1
WO2020009362A1 PCT/KR2019/007692 KR2019007692W WO2020009362A1 WO 2020009362 A1 WO2020009362 A1 WO 2020009362A1 KR 2019007692 W KR2019007692 W KR 2019007692W WO 2020009362 A1 WO2020009362 A1 WO 2020009362A1
Authority
WO
WIPO (PCT)
Prior art keywords
juice
beet
low temperature
beet juice
apple
Prior art date
Application number
PCT/KR2019/007692
Other languages
French (fr)
Korean (ko)
Inventor
함대식
Original Assignee
농업회사법인 (주)배려
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020190044885A external-priority patent/KR102134700B1/en
Application filed by 농업회사법인 (주)배려 filed Critical 농업회사법인 (주)배려
Priority to CN201980003054.4A priority Critical patent/CN110876258B/en
Priority to JP2019570850A priority patent/JP6902806B2/en
Priority to US16/626,361 priority patent/US11324245B2/en
Priority to GB1918635.2A priority patent/GB2578035B/en
Publication of WO2020009362A1 publication Critical patent/WO2020009362A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/02Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
    • A23L2/04Extraction of juices
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/42Preservation of non-alcoholic beverages
    • A23L2/50Preservation of non-alcoholic beverages by irradiation or electric treatment without heating
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52Adding ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/20Removal of unwanted matter, e.g. deodorisation or detoxification

Definitions

  • the present invention relates to a beet juice having a high intestinal absorption rate, a method for producing the same, and a use thereof, and more particularly, a beet juice having a high intestinal absorption rate by converting a high molecular compound into a low molecular weight compound through low temperature aging. It relates to an antioxidant or antihypertensive health food comprising the beet juice.
  • Beet also called red radish
  • red pigment betaine contained in beet improves muscle strength and endurance, and inhibits cell damage and antioxidants to prevent cancer and reduce inflammation. Has the effect of.
  • Korean Patent Publication No. 10-2017-0025299 compresses, matures, and freezes dried beets to minimize the loss of nutrients
  • a manufacturing method for maintaining color is disclosed
  • Korean Patent Publication No. 10-2016-0144034 manufactures beet tea having a flavor and aesthetic when drinking after mixing a beet with a functional herb, followed by a manufacturing process such as aging and heat drying.
  • the method is disclosed
  • Korean Patent Registration No. 10-0188553 discloses a method for preparing red beet juice in which red beet is immersed in an aqueous vitamin solution, extracted, filtered, and then mixed with oligosaccharides to sterilize at high temperature to preserve color and taste. .
  • beet powder or beverage prepared by the manufacturing method disclosed in the above prior document is presented only a technique for maintaining the taste and color or drinkers easily, and improves the intestinal digestive absorption rate of the active ingredient beet drink No method has been studied.
  • the present inventors have developed beet juice which improves the intestinal digestive absorption rate by improving the fishy and bitter taste of beet and converting high molecular weight compounds among the beet components into low molecular weight compounds. By confirming the effect, the present invention was completed.
  • An object of the present invention is to provide a beet juice beverage having high intestinal digestive absorption by converting a high molecular compound in a beet into a low molecular compound through low temperature aging.
  • Still another object of the present invention is to provide a method for preparing beet juice having high intestinal digestive absorption rate by converting high molecular weight compounds into low molecular weight compounds through low temperature aging.
  • Still another object of the present invention is to provide an antioxidant health food comprising low-temperature ripening beet juice by converting a high molecular compound in the beet into a low molecular weight compound through low temperature aging to increase intestinal digestive absorption.
  • Still another object of the present invention is to provide a blood pressure-lowering health food comprising low-temperature ripening beet juice by converting a high molecular compound in a beet into a low molecular compound through low temperature aging.
  • the present invention comprises a first step of washing the beet and then heating for 30 seconds to 1 minute at 200 to 300 °C;
  • It provides a method for producing beet juice comprising a; the fourth step of mixing carrot juice, apple juice and lemon juice in low temperature ripening beet juice.
  • the present invention provides a beet juice drink with improved intestinal digestive absorption, including carrot juice, apple juice and lemon juice after low-temperature aging peeled baked beet juice.
  • the present invention provides a healthy food for antioxidant, including low-temperature ripening beet juice, carrot juice and apple juice of peeled and baked beet juice.
  • the present invention provides a use of the low-temperature ripening beet juice, carrot juice and apple juice of peeled and baked beet juice as a health food for antioxidants.
  • the present invention provides a health food for antihypertension, including low-temperature ripening beet juice, carrot juice and apple juice of peeled and baked beet juice.
  • the present invention provides a use of the low-temperature ripening low-temperature ripening beet juice, carrot juice and apple juice of peeled and baked beet juice as a health food for antihypertensive.
  • beet juice can be removed through the baking process to remove the smell of fish, and low-temperature aging process to convert the high molecular compound into a low molecular compound to increase intestinal digestive absorption, carrot juice, apple juice and / or It can be mixed with lemon juice to reduce the fishy bitterness and bitter taste to produce beet juice with a sweet taste.
  • beet juice according to the present invention contains a polyphenol, has an antioxidant activity such as DPPH radical and ABTS radical scavenging ability, exhibits the effect of lowering blood pressure, increasing blood nitrite and decreasing MDA upon oral administration through animal experiments, There is no significant change in body weight and organ index, and by confirming that it has an effect of improving hypertension, such as improving vascular reactivity to acetylcholine, it can be usefully used as a health food for antioxidant or antihypertensive.
  • an antioxidant activity such as DPPH radical and ABTS radical scavenging ability
  • 1 is a bit juice prepared according to the present invention.
  • Figure 2 is a graph showing the results of measuring the total polyphenol content of beet juice prepared according to the present invention.
  • Figure 3 is a graph showing the DPPH radical scavenging activity measurement results of beet juice prepared according to the present invention.
  • Figure 5 is a graph showing the antioxidant activity measurement results by the FRAP method of beet juice prepared according to the present invention.
  • Figure 6 is a graph showing the results of measuring the betanin (betanin) content of beet juice prepared according to the present invention.
  • FIG. 7 is a graph showing changes in blood pressure after oral administration once in an animal experiment on beet juice prepared according to the present invention.
  • Figure 8 is a graph showing the blood pressure change after repeated administration in the animal experiment for beet juice prepared according to the present invention.
  • Figure 9 is a graph showing the relaxation of the blood vessels extracted in the animal experiments on beet juice prepared according to the present invention.
  • Figure 10 is a graph showing the weight change of the organ in the animal experiments on beet juice prepared according to the present invention.
  • FIG. 11 is a graph showing changes in blood Nitrite in animal experiments on beet juice prepared according to the present invention.
  • bit juice manufacturing method of the present invention will be described in detail.
  • the present invention is a first step of washing for 30 seconds to 1 minute at 200 to 300 °C after washing the beat;
  • It comprises a fourth step of mixing carrot juice, apple juice and lemon juice in low-temperature ripening beet juice.
  • the first step is to bake for 30 seconds to 1 minute at 200 to 300 °C after removing the shell of the beet.
  • the shell portion of the beet is not evenly baked, so the flavor is reduced, and if the temperature is higher or longer than the temperature range, the yeast enzyme is killed and the effect is not preferable.
  • the baked beet is juiced (step 2).
  • the second step may be juiced using a juicer.
  • the third step is preferably low-temperature aging in the storage of 0 to 10 °C, more preferably low-temperature aging in the storage of 4 to 5 °C.
  • the low temperature aging is good to proceed for 3 to 4 days.
  • the temperature is too low below 0 °C frozen beet juice is impossible to ripen, at a temperature above 10 °C juice is turned into a sticky state is not suitable for drinking.
  • the fourth step it is preferable to mix the beet juice, carrot juice, apple juice and lemon juice aged at low temperature in a ratio of 20 to 40 parts by weight, 10 to 20 parts by weight, 30 to 50 parts by weight, and 0.5 to 1 parts by weight, respectively. .
  • the carrot juice, apple juice and lemon juice are intended to improve the fishy bitterness and bitter taste of the beet, when the blending ratio is low, the fishy bitter taste and bitter taste of the beet can be felt by the drinkers, the blending ratio is higher than the beet Carrots, apples, lemons, etc. taste a lot, you can lose the benefits of beet juice.
  • Carrot juice, apple juice and lemon juice in the fourth step is preferably washed after washing the carrot, apple and lemon respectively.
  • the juice process may use a juicer.
  • the method may further include sterilizing and packaging the mixed solution prepared through the fourth step.
  • the sterilization is preferably a non-heated low temperature sterilization of 40 ° C. or less using a pulsed electric field (PEF).
  • PEF pulsed electric field
  • the yeast enzyme of beet begins to die at 40 ° C and completely dies at 60 ° C. Therefore, pasteurization at 40 ° C or lower is preferable.
  • the present invention provides a beet juice drink with improved gut digestive absorption, including peeled and baked beet juice low-temperature aging liquid, carrot juice, apple juice and lemon juice.
  • the beet juice beverage has a reddish bitterness of dark red or burgundy color and is easy to be packaged in a glass container in a non-sticky liquid form.
  • the beet juice beverage converts the polymer compound into a low molecular weight compound through a low temperature aging process, and the red color characteristic of the beet does not come out from the stool after drinking, so the digestive absorption rate of the intestine is excellent and the fishy smell can be removed through the beating process. It is mixed with carrot juice, apple juice and lemon juice to reduce fishy and bitter taste and is suitable for drinking.
  • the present invention provides a beet juice drink with improved intestinal digestive absorption, including peeled baked beet juice low-temperature aging liquid and apple juice.
  • the low-temperature ripening beet juice and apple juice is preferably blended in a weight ratio of 3: 7.
  • blend low temperature ripening beet juice, carrot juice, and apple juice by the weight ratio of 2.0-3.0: 1.5-2.5: 5.0-6.0, and it is more preferable to mix
  • the present invention provides a healthy food for antioxidant, including low-temperature ripening beet juice, carrot juice and apple juice of peeled and baked beet juice.
  • the low-temperature ripening beet juice, carrot juice and apple juice is preferably blended in a weight ratio of 2.0 to 3.0: 1.5 to 2.5: 5.0 to 6.0, it is formulated in a weight ratio of 2.5: 2: 5.5 More preferred.
  • the antioxidant health food it is preferable to further include lemon juice for flavor and flavor.
  • the health food may be a health functional food or health supplement food.
  • the present invention also provides an antioxidant health food comprising peeled beet juice, low temperature ripening low temperature ripening beet juice and apple juice.
  • low-temperature ripening beet juice and apple juice is preferably blended in a weight ratio of 3: 7.
  • the health food may be a health functional food or health supplement food.
  • the present invention provides a health food for antihypertension, including low-temperature ripening beet juice, carrot juice and apple juice of peeled and baked beet juice.
  • low temperature ripening beet juice, carrot juice and apple juice are preferably blended in a weight ratio of 2.0 to 3.0: 1.5 to 2.5: 5.0 to 6.0, and blended in a weight ratio of 2.5: 2: 5.5. More preferably.
  • the antihypertensive health food it is preferable to further include lemon juice for flavors and flavors.
  • the health food may be a health functional food or health supplement food.
  • the present invention provides a health food for antihypertension, including low-temperature ripening beet juice and apple juice of the peeled and baked beet juice.
  • low temperature ripening beet juice and apple juice are preferably blended in a weight ratio of 3: 7.
  • the health food may be a health functional food or health supplement food.
  • the health food of the present invention may be used as it is, beet juice according to the present invention as it is or in combination with other food or food ingredients, and may be appropriately used according to a conventional method.
  • the health food of the present invention may be used, including beet juice 50 to 99 parts by weight based on 100 parts by weight of the whole health food composition.
  • Examples of foods to which the beet juice may be added include beverages, alcoholic beverages, dairy products, meats, noodles, confectionery, ice cream, and the like, and include all health foods in a general sense.
  • the health food of the present invention may include various flavors or sweeteners, such as conventional beverages, and various nutritional agents, vitamins, electrolytes, flavoring agents, coloring agents, pectic acid and salts thereof, alginic acid and salts thereof, organic acids, Protective colloid thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohols, carbonation agents used in carbonated beverages and the like, and may contain a variety of other flesh. These components can be used independently or in combination. The proportion of such additives is not critical, but is usually selected in the range of 0.01 to 0.1 parts by weight per 100 parts by weight of the whole health food composition.
  • the mixture thus prepared was completed by unheated pasteurization using a pulsed electric field (PEF).
  • PEF pulsed electric field
  • Beet juice was prepared in the same manner as in Example 1, except that the beet juice was subjected to low temperature aging for 3 days in a 10 °C storage.
  • Beet juice was prepared in the same manner as in ⁇ Example 1> except that the juice was aged for 3 days at room temperature (20 ⁇ 25 °C).
  • the sensory test was performed to determine the taste, aroma and overall acceptability of the beet juice prepared in Examples 1 to 4 and Comparative Examples 1 to 7, respectively.
  • Sensory test personnel consisted of 20 adult males and 20 adult females (5 males, 20 females, 5 females in 30s, 5 females in 40s, and 5 females in 50s). After establishing stable criteria for characteristics and tastes, they went to the sensory test. The sensory evaluation items were evaluated based on a score of 10 out of 4 items in total: taste, aroma, texture, and overall preference.
  • the scoring criteria are as follows.
  • Example 1 9.2 9.5 9.0 9.3
  • Example 2 9.0 9.3 8.5 9.3
  • Example 3 9.2 9.1 8.9 9.0
  • Example 4 9.2 9.5 8.3 8.9 Comparative Example 1 5.8 4.2 6.2 5.5 Comparative Example 2 5.9 4.1 6.0 5.1 Comparative Example 3 5.1 4.4 5.8 4.8 Comparative Example 4 5.7 4.0 6.0 4.7 Comparative Example 5 5.0 4.0 5.9 4.9 Comparative Example 6 5.2 4.0 6.0 4.9 Comparative Example 7 5.5 4.0 6.0 5.3
  • the beet juice prepared according to Examples 1 to 4 is removed by heating the beet epidermis to remove odors and has a pleasant aroma, and the flavor is improved by properly mixing carrot juice, apple juice and lemon juice.
  • the beet juice preserved as it is without killing the yeast enzyme in the beet by maintaining an appropriate low temperature.
  • the beet juice prepared by Comparative Example 1 did not go through the step of heating the beet separately, so the person could feel the natural fishy, sour taste and sensitive to the smell.
  • yeast enzyme in the beet was killed and its fragrance was not good. Found to be low.
  • the mixing conditions were different as in ⁇ Comparative Examples 5 to 6>, the unique fishy bitterness and bitter taste were strongly felt, and the beet juice prepared by ⁇ Comparative Example 7> was sterilized at high temperature to kill yeast enzyme. And the texture was not good.
  • the juice was taken one cup of 250 ml per day for one week, and was carried out so as not to consume another fruit or fruit juice from three days before the experiment until the end.
  • Digestive absorption was evaluated for a total of three points out of 10 points out of the state of stools, comfort and stomach comfort during the week, and the color of the stool was visually observed.
  • the scoring criteria are as follows.
  • Example 1 No big difference from normal discoloration 8.5 8.6
  • Example 2 8.0 8.1 8.4
  • Example 3 8.0 8.2 8.5
  • the beet juice prepared according to Examples 1 to 4 showed that the stool state, the degree of pleasure, and the comfort of the subjects showed more than 8.0 good for most of the subjects. No difference was found.
  • Sample 2 (Sample 2; S2), the low-temperature ripening beet juice, carrot juice and apple juice were mixed in a weight ratio of 2.5: 2: 5.5, respectively, in the same manner as in ⁇ Example 1> beet juice improved intestinal absorption Was prepared.
  • sample 1 (Sample 1; S1), a beet stock solution in which the beet was juiced as it was prepared was prepared.
  • sample 3 As sample 3 (S3), beet juice obtained by diluting the beet juice of sample 2 with distilled water twice was prepared.
  • Flavonoids are chemicals found in plants. Flavonoids, catechins, and tannins are known to have antioxidant, anti-cancer, and antihypertensive effects.
  • Total polyphenol content was measured using the Folin-Deni method. 100 ⁇ L of Folin-ciocalteus' phenol reagent was added to each of the prepared 1 mL samples 1 to 3, followed by reaction at room temperature for 5 minutes, followed by 200 ⁇ L of Na 2 CO 3 solution (7%, w / v) and 700 ⁇ L of distilled water. The reaction was time. After the reaction, the absorbance was measured at 720 nm, and the total polyphenol content of the extract was expressed using a standard calibration curve prepared using gallic acid.
  • Example ⁇ 3-1> Sample 1 (Sample 1; S1), Sample 2 (Sample 2; S2), and Sample 3 (Sample 3; S3) were prepared.
  • DPPH radical scavenging activity is a relatively simple method of measuring antioxidant activity. It is a method of measuring antioxidant activity using the principle that DPPH receives an electron or hydrogen from a phenolic compound or the like and is purple when the PHPH is reduced.
  • DPPH radical scavenging activity experiment was used using the Blosis method. After mixing at room temperature, the sample prepared with 0.2 mM DPPH and each stand for 10 minutes using ELASA reader SpectraMax ® M3 Multi-Mode Microplate Reader (Molecular Devices, Sunnyvale, CA, USA) was measured at 517nm. The absorbance of DPPH was expressed by the concentration of the sample (SC50), which was reduced by 50%. Each sample was repeated three times to obtain an average value. Vitamin C was used as a control.
  • Example ⁇ 3-1> Sample 1 (Sample 1; S1), Sample 2 (Sample 2; S2), and Sample 3 (Sample 3; S3) were prepared.
  • ABTS radical scavenging activity was prepared by mixing 7.4 mM ABTS and 2.6 mM potassium persulfate and leaving it in the dark at room temperature for 15 hours to form radicals. The solution was then prepared to have an absorbance of 0.70 ⁇ 0.02 at 734 nm. 20 ⁇ L of each sample was added to 180 ⁇ L of the prepared ABTS solution, and the mixture was left at room temperature for 15 minutes, and then absorbance was measured at 734 nm. ABTS radical scavenging activity was expressed as a percentage difference in absorbance between the sample solution addition group and the no addition group.
  • Example ⁇ 3-1> Sample 1 (Sample 1; S1), Sample 2 (Sample 2; S2), and Sample 3 (Sample 3; S3) were prepared.
  • FRAP method measures the antioxidant activity by measuring the change in absorbance generated during reduction is tripyridyltriazine ferric (Fe + 3) at low pH to tripyridyltriazine ferrous (Fe + 2) by an antioxidant.
  • Antioxidant activity by FRAP (ferric reducing antioxidant power) method was carried out according to the method of Benzie and Strain.
  • 40 ⁇ L of each sample, 100 ⁇ L of FRAP substrate solution, and 200 ⁇ L of distilled water were sequentially mixed in a 96-well plate and reacted at 37 ° C. for 4 minutes, and the absorbance was measured at 593 nm.
  • Each sample was repeated three times, and analyzed using a standard calibration curve obtained using FeSO 4 ⁇ 7H 2 O as a standard.
  • Example ⁇ 3-1> Sample 1 (Sample 1; S1), Sample 2 (Sample 2; S2), and Sample 3 (Sample 3; S3) were prepared.
  • Betanin analysis was performed using 1200 series HPLC (Agilent Technologies, CA, USA) equipped with Synergi 4 ⁇ POLAR-RP 80A column (250 ⁇ 4.6 mm, 4 ⁇ m Phenomenex). Analytical conditions were analyzed by setting a detection wavelength of 538 nm, a flow rate of 1.0 mL / min, and a column temperature of 35 ° C. Samples were injected with 20.0 ⁇ L using an automatic injector. As a mobile phase solvent, solvent A [water: formic acid, (99: 1, v / v)] and solvent B (acetonitrile, CH3CN) were used. Solvent concentration gradient was performed based on solvent B and took a total of 25 minutes analysis time.
  • solvent A water: formic acid, (99: 1, v / v)
  • solvent B acetonitrile, CH3CN
  • Solvent B initially started at 0% and increased to 20% by 15 minutes and then 40% by 20 minutes. It rapidly decreased to 0% at 20.1 minutes and then held at 0% until 25 minutes.
  • the analyzed components were identified by the same retention time (RT) of betanin, an external standard, and quantified by comparing the peak areas of each betaine component based on the HPLC peak area (area).
  • Experimental animals used a 24 week old female congenital hypertensive rat (SHR).
  • the environment of experimental animal breeding room was 23 ⁇ 2 °C and relative humidity 50 ⁇ 10%, and the contrast period was controlled in 12 hours (lighting time 08: 00-20: 00). All animal experiments were performed with the approval of the Jeju Experimental Ethics Committee of Jeju National University (Approval No .: 2018-0053).
  • the experimental group was as follows when repeated administration.
  • Group 1 SHR (drinking water, ad libitum)
  • the change in blood pressure was observed for 24 hours after oral administration to one SHR per sample.
  • the experimental group was as follows.
  • Group 1 SHR + D.W. (0.6 ml / rat, p.o.)
  • Group 4 SHR + betanin (50 mg / kg, p.o.)
  • Blood pressure was measured using a CODA non-invasive blood pressure system (Kent Scientific, Torrington, CT). Before the blood pressure measurement, the tail temperature of the test animal was maintained at 32-35 ° C., and blood pressure was measured while stabilizing. Mean blood pressure of SHR ranged from 177 to 182 mmHg.
  • FIG. 7 In case of Sample 2, a gradual blood pressure lowering effect was observed up to 4 hours after administration, and then returned to the original blood pressure. On the other hand, when the sample 1 was administered, there was a tendency of the blood pressure to be inadequate, and the betanin administration was not different from the control group.
  • the experimental animals were treated with Group 1: control group (SHR), Group 2: sample 1 administration group (30 ml / day), Group 3: sample 2 diluted with distilled water (30 ml / day) and Group 4: sample 2 stock solution (30 ml / day) was divided into four groups of each group was tested for 3 weeks. Samples were administered orally within 30 minutes, after which the drinking and feeding were free.
  • the experimental group was as follows.
  • Group 1 SHR + D.W. (0.6 ml / rat, p.o.)
  • Group 4 SHR + betanin (50 mg / kg, p.o.)
  • Blood pressure was measured using a CODA non-invasive blood pressure system (Kent Scientific, Torrington, CT). Before the blood pressure measurement, the tail temperature of the test animal was maintained at 32-35 ° C., and blood pressure was measured while stabilizing.
  • Sample 1 administration group (G1) showed a tendency of continuous increase in blood pressure after 2 days.
  • the sample 2 administration group showed a blood pressure lowering effect in proportion to the dose of sample 2 (G3, G4).
  • sample 2 has an effect of improving hypertension.
  • the thoracic aorta was extracted to create an aortic ring of 3-5 mm and Krebs solution (in mM, NaCl 120, KCl 4.75, Glucose 6.4, NaHCO 3 25, KH 2 PO 4 1.2, MgSO 4 1.2 and CaCl 2 1.7) were suspended in an organ bath.
  • Krebs solution in mM, NaCl 120, KCl 4.75, Glucose 6.4, NaHCO 3 25, KH 2 PO 4 1.2, MgSO 4 1.2 and CaCl 2 1.7
  • the temperature was maintained at 37 ° C. and the pH of the solution was maintained at 7.4 by feeding carbogen (95% O 2 , 5% CO 2 ).
  • carbogen 95% O 2 , 5% CO 2 .
  • the resting tension of the aortic ring was adjusted to 1.5 g and then stabilized for 1 hour with a solution change every 20 minutes.
  • Vasoconstrictor response is recorded with a physiograph recorder (PowerLab / 400, AD instruments, USA) by connecting the other end of the fixed aortic ring to an isometric force-displacement transducer (FT03, Grass, AD instruments, USA), and the Chart8 program. Analyzed. Endothelial cell-dependent relaxation experiments were performed by treating 10 -6 M of phenylephrine (PE) to endothelial cells, and then contracting the blood vessels before releasing them and applying acetylcholine (Ach) cumulatively (10 -9 to 10 -4 M). The reaction was observed and pD 2 (-Log EC 50 ) was calculated.
  • PE phenylephrine
  • Ach acetylcholine
  • Organ weight index organ weight ⁇ body weight x 100 (%)
  • Serum nitrite concentration was measured by Miranda et al. Two volumes of ethanol were added to the serum and centrifuged at 3000 rpm for 10 minutes to remove proteins. 100 ⁇ L of the supernatant was added with the same amount of vanadium (III) chloride to convert nitrate to nitrite. Thereafter, 50 ⁇ L each of Griess reagent sulfanilamide and N- (1-naphthyl) ethylenediamine were added thereto, and reacted at 37 ° C. for 3 hours, and the absorbance at 570 nm was measured.
  • Serum MDA content was measured using EZ-Lipid peroxidation (TBARS) assay kit (DoGenBio, Seoul). After supernatant was added 35 mg of TCA to the serum by centrifugation. The same amount of indicator was added to 200 ⁇ L of the supernatant and reacted at 65 ° C. for 45 minutes, and the absorbance was measured at 540 nm.
  • TBARS EZ-Lipid peroxidation
  • Sample 2 showed significant blood pressure lowering effects, increased blood nitrite, and decreased MDA when administered orally to hypertensive animals. Vascular responsiveness was improved.

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to beet juice having an increased intestinal absorption rate, a preparation therefor and a use thereof and, more specifically, to: beet juice, which has an enhanced intestinal digestion and absorption rate through the conversion of high-molecular compounds into low-molecular compounds by means of low-temperature maturation of beets, has a grassy smell removed therefrom through the roasting of beets, and has a reduced grassy taste and bitterness by being mixed with carrot juice and apple juice; and an antioxidant or antihypertensive health food composition using the beet juice.

Description

장내 흡수율을 높인 비트주스, 이의 제조방법 및 이의 용도Beet juice with high intestinal absorption, preparation method thereof and use thereof
본 발명은 장내 흡수율을 높인 비트주스, 이의 제조방법 및 이의 용도에 관한 것으로서, 보다 상세하게는 저온 숙성을 통해 비트 내 고분자화합물을 저분자화합물로 변환하여 장내 흡수율을 높인 비트주스, 이를 제조하는 방법 및 상기 비트주스를 포함하는 항산화 또는 항고혈압용 건강식품에 관한 것이다.The present invention relates to a beet juice having a high intestinal absorption rate, a method for producing the same, and a use thereof, and more particularly, a beet juice having a high intestinal absorption rate by converting a high molecular compound into a low molecular weight compound through low temperature aging. It relates to an antioxidant or antihypertensive health food comprising the beet juice.
빨간 무라고도 불리는 비트(Beet)는 풍부한 영양소를 가지고 있으며, 비트에 포함된 붉은 색소 베타인(Betaine)은 근력과 지구력을 향상시켜주며, 세포 손상을 억제하고 항산화 작용을 가져 암 예방, 염증 완화 등의 효과를 가지고 있다.Beet, also called red radish, is rich in nutrients, and the red pigment betaine contained in beet improves muscle strength and endurance, and inhibits cell damage and antioxidants to prevent cancer and reduce inflammation. Has the effect of.
또한, 철분과 비타민이 다량 함유되어 있어 적혈구의 생성을 돕고, 혈액을 깨끗하게 해주어 월경불순이나 갱년기 여성에게도 좋으며, 위 손상을 막아주고 위 점막을 보호해주고 식이섬유가 많아 변비 해소에도 좋은 효능을 가지고 있다.In addition, it contains a large amount of iron and vitamins, which helps to produce red blood cells, and cleans the blood, which is good for menstrual irregularities and menopausal women.It also helps to prevent stomach damage, protect the gastric mucosa, and has a lot of dietary fiber. .
비트는 요리하여 먹는 것도 좋지만 영양소를 살리기 위해 생것 그대로 샐러드나 생채로 먹으면 좋은데, 비트 특유의 비린맛과 쓴맛 때문에 섭취하는데 어려움이 있다. 아울러, 비트를 생것 그대로 먹었을 때, 비트에 포함된 고분자 화합물이 체내에서 흡수가 빨리 되지 않는 단점을 가지고 있다. It is also good to eat beet, but it is good to eat as raw salad or raw vegetables to save nutrients, but it is difficult to eat because of the unique fishy bitterness and bitter taste. In addition, when the beet is eaten raw, there is a disadvantage that the polymer compound contained in the beet is not quickly absorbed in the body.
따라서 비트를 용이하게 섭취하기 위한 연구가 이어지고 있는데, 예를 들면, 한국특허공개번호 10-2017-0025299에는 비트를 압착, 숙성시킨 뒤 동결 건조시켜 분말화하여 영양성분 손실을 최소화하고 비트의 맛과 색을 유지하는 제조방법이 개시되어 있으며, 한국특허공개번호 10-2016-0144034에는 비트와 기능성 허브를 혼합한 뒤 숙성, 가열건조 등의 제조과정을 거쳐 음용 시 풍미와 심미성을 가지게 하는 비트 차 제조방법이 개시되어 있으며, 한국특허등록번호 10-0188553에는 레드비트를 비타민 수용액에 침적시킨 뒤 추출, 여과하고 이후 올리고당을 혼합해 고온 살균하여 색상과 맛을 보존하는 레드비트 주스 제조방법이 개시되어 있다.Therefore, research is being conducted to easily consume beet. For example, Korean Patent Publication No. 10-2017-0025299 compresses, matures, and freezes dried beets to minimize the loss of nutrients, A manufacturing method for maintaining color is disclosed, and Korean Patent Publication No. 10-2016-0144034 manufactures beet tea having a flavor and aesthetic when drinking after mixing a beet with a functional herb, followed by a manufacturing process such as aging and heat drying. The method is disclosed, and Korean Patent Registration No. 10-0188553 discloses a method for preparing red beet juice in which red beet is immersed in an aqueous vitamin solution, extracted, filtered, and then mixed with oligosaccharides to sterilize at high temperature to preserve color and taste. .
그러나 위와 같은 선행문헌에 개시된 제조방법으로 제조된 비트 분말 또는 음료는 맛과 색깔을 유지하거나 음용자들이 쉽게 마실 수 있는 방법에 대한 기술만 제시되어 있을 뿐, 비트 음료 유효 성분의 장내 소화흡수율을 높이는 방법에 대한 것은 연구된 바 없다. However, the beet powder or beverage prepared by the manufacturing method disclosed in the above prior document is presented only a technique for maintaining the taste and color or drinkers easily, and improves the intestinal digestive absorption rate of the active ingredient beet drink No method has been studied.
이에 본 발명자들은 비트의 비린맛, 쓴맛을 개선하고 비트 성분 가운데 고분자 화합물을 저분자 화합물로 변환시켜 장내 소화 흡수율을 높이는 비트주스를 개발하였으며, 상기 장내 소화 흡수율을 높이는 비트주스가 우수한 항산화 활성 및 혈압 강하 효과가 있음을 확인함으로써, 본 발명을 완성하였다. Accordingly, the present inventors have developed beet juice which improves the intestinal digestive absorption rate by improving the fishy and bitter taste of beet and converting high molecular weight compounds among the beet components into low molecular weight compounds. By confirming the effect, the present invention was completed.
본 발명의 목적은 저온 숙성을 통해 비트 내 고분자화합물을 저분자화합물로 변환하여 장내 소화흡수율을 높인 비트주스 음료를 제공하는 것이다.SUMMARY OF THE INVENTION An object of the present invention is to provide a beet juice beverage having high intestinal digestive absorption by converting a high molecular compound in a beet into a low molecular compound through low temperature aging.
본 발명의 또 다른 목적은 저온 숙성을 통해 비트 내 고분자화합물을 저분자화합물로 변환하여 장내 소화흡수율을 높인 비트주스를 제조하는 방법을 제공하는 것이다.Still another object of the present invention is to provide a method for preparing beet juice having high intestinal digestive absorption rate by converting high molecular weight compounds into low molecular weight compounds through low temperature aging.
본 발명의 또 다른 목적은 저온 숙성을 통해 비트 내 고분자화합물을 저분자화합물로 변환하여 장내 소화흡수율을 높인 저온 숙성 비트즙을 포함하는 항산화용 건강식품을 제공하는 것이다.Still another object of the present invention is to provide an antioxidant health food comprising low-temperature ripening beet juice by converting a high molecular compound in the beet into a low molecular weight compound through low temperature aging to increase intestinal digestive absorption.
본 발명의 또 다른 목적은 저온 숙성을 통해 비트 내 고분자화합물을 저분자화합물로 변환하여 장내 소화흡수율을 높인 저온 숙성 비트즙을 포함하는 혈압강하용 건강식품을 제공하는 것이다. Still another object of the present invention is to provide a blood pressure-lowering health food comprising low-temperature ripening beet juice by converting a high molecular compound in a beet into a low molecular compound through low temperature aging.
상기 목적을 달성하기 위하여, In order to achieve the above object,
본 발명은 비트를 세척한 후 200 내지 300℃에서 30초 내지 1분간 가열하는 제1 단계;The present invention comprises a first step of washing the beet and then heating for 30 seconds to 1 minute at 200 to 300 ℃;
구운 비트를 착즙하는 제2 단계;A second step of juice the baked beet;
착즙액을 0 내지 10℃에서 3일 내지 4일간 저온 숙성하는 제3 단계; 및A third step of ripening the juice at 0 to 10 ° C. for 3 to 4 days at low temperature; And
저온 숙성 비트즙에 당근즙, 사과즙 및 레몬즙을 혼합하는 제4 단계;를 포함하는 비트주스의 제조방법을 제공한다.It provides a method for producing beet juice comprising a; the fourth step of mixing carrot juice, apple juice and lemon juice in low temperature ripening beet juice.
또한, 본 발명은 껍질을 벗겨서 구운 비트 착즙액을 저온 숙성시킨 후, 당근즙, 사과즙 및 레몬즙을 포함하는 장내 소화흡수율이 향상된 비트주스 음료를 제공한다.In addition, the present invention provides a beet juice drink with improved intestinal digestive absorption, including carrot juice, apple juice and lemon juice after low-temperature aging peeled baked beet juice.
또한, 본 발명은 껍질을 벗겨서 구운 비트 착즙의 저온 숙성한 저온 숙성 비트즙, 당근즙 및 사과즙을 포함하는 항산화용 건강식품을 제공한다.In addition, the present invention provides a healthy food for antioxidant, including low-temperature ripening beet juice, carrot juice and apple juice of peeled and baked beet juice.
또한, 본 발명은 껍질을 벗겨서 구운 비트 착즙의 저온 숙성한 저온 숙성 비트즙, 당근즙 및 사과즙을 항산화용 건강식품으로 이용하는 용도를 제공한다.In another aspect, the present invention provides a use of the low-temperature ripening beet juice, carrot juice and apple juice of peeled and baked beet juice as a health food for antioxidants.
또한, 본 발명은 껍질을 벗겨서 구운 비트 착즙의 저온 숙성한 저온 숙성 비트즙, 당근즙 및 사과즙을 포함하는 항고혈압용 건강식품을 제공한다.In addition, the present invention provides a health food for antihypertension, including low-temperature ripening beet juice, carrot juice and apple juice of peeled and baked beet juice.
아울러, 본 발명은 껍질을 벗겨서 구운 비트 착즙의 저온 숙성한 저온 숙성 비트즙, 당근즙 및 사과즙을 항고혈압용 건강식품으로 이용하는 용도를 제공한다.In addition, the present invention provides a use of the low-temperature ripening low-temperature ripening beet juice, carrot juice and apple juice of peeled and baked beet juice as a health food for antihypertensive.
본 발명은 비트주스 제조 시, 비트를 굽는 과정을 통해 비린 냄새를 제거할 수 있고, 저온 숙성 과정을 통해 고분자 화합물을 저분자 화합물로 변환하여 장내 소화흡수율을 높일 수 있으며, 당근즙, 사과즙 및/또는 레몬즙과 혼합하여 비린 맛과 쓴맛을 완화시켜 감미로운 맛을 가지는 비트주스를 제조할 수 있다.In the present invention, beet juice can be removed through the baking process to remove the smell of fish, and low-temperature aging process to convert the high molecular compound into a low molecular compound to increase intestinal digestive absorption, carrot juice, apple juice and / or It can be mixed with lemon juice to reduce the fishy bitterness and bitter taste to produce beet juice with a sweet taste.
또한, 본 발명에 따른 비트주스는 폴리페놀을 함유하고, DPPH 라디칼 및 ABTS 라디칼 소거능 등의 항산화 활성을 가지며, 동물 실험을 통한 경구 투여시 혈압 강하, 혈중 nitrite의 증가 및 MDA의 감소 효과를 나타내고, 체중과 장기지표(organ index)에는 유의한 변화가 없으며, 아세틸콜린에 대한 혈관 반응성을 개선시키는 등의 고혈압 개선 효과를 가지는 것을 확인함으로써, 항산화용 또는 항고혈압용 건강식품으로 유용하게 사용될 수 있다. In addition, beet juice according to the present invention contains a polyphenol, has an antioxidant activity such as DPPH radical and ABTS radical scavenging ability, exhibits the effect of lowering blood pressure, increasing blood nitrite and decreasing MDA upon oral administration through animal experiments, There is no significant change in body weight and organ index, and by confirming that it has an effect of improving hypertension, such as improving vascular reactivity to acetylcholine, it can be usefully used as a health food for antioxidant or antihypertensive.
도 1은 본 발명에 따라 제조된 비트주스이다.1 is a bit juice prepared according to the present invention.
도 2는 본 발명에 따라 제조된 비트주스의 총 폴리페놀 함량 측정 결과를 보여주는 그래프이다.Figure 2 is a graph showing the results of measuring the total polyphenol content of beet juice prepared according to the present invention.
도 3은 본 발명에 따라 제조된 비트주스의 DPPH 라디칼 소거활성 측정 결과를 보여주는 그래프이다.Figure 3 is a graph showing the DPPH radical scavenging activity measurement results of beet juice prepared according to the present invention.
도 4는 본 발명에 따라 제조된 비트주스의 ABTS 라디칼 소거활성 측정 결과를 보여주는 그래프이다.4 is a graph showing the results of measuring ABTS radical scavenging activity of beet juice prepared according to the present invention.
도 5는 본 발명에 따라 제조된 비트주스의 FRAP법에 의한 항산화 활성 측정 결과를 보여주는 그래프이다.Figure 5 is a graph showing the antioxidant activity measurement results by the FRAP method of beet juice prepared according to the present invention.
도 6은 본 발명에 따라 제조된 비트주스의 베타닌(betanin) 함량 측정 결과를 보여주는 그래프이다.Figure 6 is a graph showing the results of measuring the betanin (betanin) content of beet juice prepared according to the present invention.
도 7은 본 발명에 따라 제조된 비트주스에 대한 동물실험에서의 1회 경구 투여 후 혈압변화를 보여주는 그래프이다.7 is a graph showing changes in blood pressure after oral administration once in an animal experiment on beet juice prepared according to the present invention.
도 8은 본 발명에 따라 제조된 비트주스에 대한 동물실험에서의 반복 투여 후 혈압변화를 보여주는 그래프이다.Figure 8 is a graph showing the blood pressure change after repeated administration in the animal experiment for beet juice prepared according to the present invention.
도 9는 본 발명에 따라 제조된 비트주스에 대한 동물실험에서의 적출 혈관의 이완성을 보여주는 그래프이다.Figure 9 is a graph showing the relaxation of the blood vessels extracted in the animal experiments on beet juice prepared according to the present invention.
도 10은 본 발명에 따라 제조된 비트주스에 대한 동물실험에서의 장기의 중량 변화를 보여주는 그래프이다.Figure 10 is a graph showing the weight change of the organ in the animal experiments on beet juice prepared according to the present invention.
도 11은 본 발명에 따라 제조된 비트주스에 대한 동물실험에서의 혈중 Nitrite 변화를 보여주는 그래프이다.FIG. 11 is a graph showing changes in blood Nitrite in animal experiments on beet juice prepared according to the present invention.
도 12는 본 발명에 따라 제조된 비트주스에 대한 동물실험에서의 혈중 지질산화의 지표인 MDA 변화를 보여주는 그래프이다.12 is a graph showing the change in MDA which is an indicator of blood lipid oxidation in animal experiments for beet juice prepared according to the present invention.
이하, 본 발명을 상세하게 설명한다. 본 발명을 설명함에 있어서 관련된 공지 구성 또는 기능에 대한 상세한 설명은 생략할 수 있다.EMBODIMENT OF THE INVENTION Hereinafter, this invention is demonstrated in detail. In the following description of the present invention, detailed descriptions of related well-known configurations or functions may be omitted.
본 명세서 및 특허청구범위에 사용된 용어나 단어는 통상적이거나 사전적 의미로 한정되어 해석되지 아니하며, 본 발명의 기술적 사항에 부합하는 의미와 개념으로 해석되어야 한다.The terms or words used in the specification and claims are not to be construed as being limited to conventional or dictionary meanings, but should be construed as meanings and concepts corresponding to the technical matters of the present invention.
본 명세서에 기재된 실시예와 도면에 도시된 구성은 본 발명의 바람직한 실시예이며, 본 발명의 기술적 사상을 모두 대변하는 것이 아니므로, 본 출원 시점에서 이들을 대체할 수 있는 다양한 균등물과 변형예들이 있을 수 있다.The embodiments described in the specification and the configuration shown in the drawings are preferred embodiments of the present invention, and do not represent all of the technical idea of the present invention, various equivalents and modifications that can replace them at the time of the present application are There may be.
이하, 본 발명의 비트주스 제조방법에 대하여 상세히 설명하도록 한다.Hereinafter, the bit juice manufacturing method of the present invention will be described in detail.
본 발명은 비트를 세척한 후 200 내지 300℃에서 30초 내지 1분간 굽는 제1 단계;The present invention is a first step of washing for 30 seconds to 1 minute at 200 to 300 ℃ after washing the beat;
가열된 비트를 착즙하는 제2 단계;A second step of juiced the heated beet;
착즙액을 0 내지 10℃에서 3일 내지 4일간 저온 숙성하는 제3 단계; 및A third step of ripening the juice at 0 to 10 ° C. for 3 to 4 days at low temperature; And
저온 숙성 비트즙에 당근즙, 사과즙 및 레몬즙을 혼합하는 제4 단계;를 포함하는 비트주스의 제조방법을 포함한다.It comprises a fourth step of mixing carrot juice, apple juice and lemon juice in low-temperature ripening beet juice.
먼저, 비트를 세척한 후 굽는다(제 1 단계).First, wash the beat and bake (first step).
상기 제1 단계는 비트의 껍질을 제거한 후 200 내지 300 ℃에서 30초 내지 1분 간 굽는 것이 좋다.The first step is to bake for 30 seconds to 1 minute at 200 to 300 ℃ after removing the shell of the beet.
이 때, 온도 범위보다 낮거나 시간이 짧으면 비트의 껍질 부분이 골고루 구워지지 않으므로 풍미가 떨어지고, 온도 범위보다 높거나 시간이 길면 비트의 효모효소가 사멸해버려 효능이 떨어지므로 바람직하지 못하다.At this time, if the temperature range is lower or shorter than the time range, the shell portion of the beet is not evenly baked, so the flavor is reduced, and if the temperature is higher or longer than the temperature range, the yeast enzyme is killed and the effect is not preferable.
다음으로 구운 비트를 착즙한다(제2 단계).Next, the baked beet is juiced (step 2).
상기 제2 단계는 착즙기를 이용해 착즙할 수 있다.The second step may be juiced using a juicer.
다음으로 착즙액을 저온 숙성한다(제3 단계).Next, the juice is aged at low temperature (third step).
상기 제3 단계는 0 내지 10 ℃의 저장고에서 저온 숙성하는 것이 바람직하며, 4 내지 5 ℃의 저장고에서 저온 숙성하는 것이 더욱 바람직하다. The third step is preferably low-temperature aging in the storage of 0 to 10 ℃, more preferably low-temperature aging in the storage of 4 to 5 ℃.
또한, 상기 저온 숙성은 3일 내지 4일 간 진행되는 것이 좋다In addition, the low temperature aging is good to proceed for 3 to 4 days.
이 때, 0 ℃ 미만에서는 온도가 너무 낮아 비트 착즙액이 얼어버려 숙성이 불가능하며, 10 ℃ 초과의 온도에서는 착즙액이 끈적한 상태로 변해 음용하기에 적합하지 않다. At this time, the temperature is too low below 0 ℃ frozen beet juice is impossible to ripen, at a temperature above 10 ℃ juice is turned into a sticky state is not suitable for drinking.
또한, 3일 미만 숙성 시에는 비트의 비린맛, 쓴맛이 남아있어 음용하기 적합하지 않으며, 4일 이상 숙성 후 음료로 제조하였을 때는 색과 맛이 변하기 쉽다. In addition, when aged less than 3 days, the fishy bitterness, bitter taste of the beets remain unsuitable for drinking, and when prepared as a beverage after aging for 4 days or more, the color and taste is likely to change.
다음으로 저온 숙성 비트즙에 당근즙, 사과즙 및 레몬즙을 혼합한다(제4 단계).Next, carrot juice, apple juice and lemon juice are mixed with cold ripening beet juice (fourth step).
상기 제4 단계에서 저온 숙성된 비트즙과 당근즙, 사과즙 및 레몬즙을 각각 20 내지 40 중량부, 10 내지 20 중량부, 30 내지 50 중량부, 0.5 내지 1 중량부의 비율로 혼합하는 것이 바람직하다.In the fourth step, it is preferable to mix the beet juice, carrot juice, apple juice and lemon juice aged at low temperature in a ratio of 20 to 40 parts by weight, 10 to 20 parts by weight, 30 to 50 parts by weight, and 0.5 to 1 parts by weight, respectively. .
상기 당근즙, 사과즙 및 레몬즙은 비트의 비린맛과 쓴맛을 개선하기 위한 것으로 배합비율이 낮을 경우 비트의 비린맛과 쓴맛이 많이 느껴져 음용자들이 거부감을 느낄 수 있으며, 배합비율이 높을 경우 비트보다 당근, 사과, 레몬 등의 맛이 많이 느껴지며, 비트주스의 효능을 잃을 수 있다. The carrot juice, apple juice and lemon juice are intended to improve the fishy bitterness and bitter taste of the beet, when the blending ratio is low, the fishy bitter taste and bitter taste of the beet can be felt by the drinkers, the blending ratio is higher than the beet Carrots, apples, lemons, etc. taste a lot, you can lose the benefits of beet juice.
상기 제4 단계에서 당근즙, 사과즙 및 레몬즙은 당근, 사과 및 레몬을 각각 세척한 후 착즙하는 것이 바람직하다.Carrot juice, apple juice and lemon juice in the fourth step is preferably washed after washing the carrot, apple and lemon respectively.
이때, 착즙 과정은 착즙기를 이용할 수 있다.At this time, the juice process may use a juicer.
상기 제4 단계를 통해 제조된 혼합액에 멸균 및 포장하는 단계를 더 포함할 수 있다.The method may further include sterilizing and packaging the mixed solution prepared through the fourth step.
상기 멸균은 펄스전기장치(Pulsed Electric Field, PEF)를 이용하여 40℃ 이하의 비가열 저온 멸균하는 것이 바람직하다. The sterilization is preferably a non-heated low temperature sterilization of 40 ° C. or less using a pulsed electric field (PEF).
이 때, 비트의 효모효소는 40℃부터 사멸하기 시작하여 60℃가 되면 완전히 사멸되어버리므로, 40℃이하에서 저온 살균하는 것이 바람직하다.At this time, the yeast enzyme of beet begins to die at 40 ° C and completely dies at 60 ° C. Therefore, pasteurization at 40 ° C or lower is preferable.
또한, 본 발명은 껍질을 벗겨서 구운 비트 착즙 저온 숙성액, 당근즙, 사과즙 및 레몬즙을 포함하는 장내 소화흡수율이 향상된 비트주스 음료를 제공한다.In addition, the present invention provides a beet juice drink with improved gut digestive absorption, including peeled and baked beet juice low-temperature aging liquid, carrot juice, apple juice and lemon juice.
상기 비트주스 음료는 레트비트 색인 진한 붉은색 또는 와인색을 띄며, 끈적끈적하지 않은 액체형태로 유리용기에 포장하기 용이하다.The beet juice beverage has a reddish bitterness of dark red or burgundy color and is easy to be packaged in a glass container in a non-sticky liquid form.
상기 비트주스 음료는 저온 숙성 과정을 통해 고분자화합물을 저분자화합물로 변환시키며, 음용 후 변에서 비트 특유의 붉은색이 나오지 않아 장내 소화흡수율이 우수하고, 비트를 굽는 과정을 통해 비린 냄새를 제거할 수 있으며, 당근즙, 사과즙 및 레몬즙과 혼합하여 비린 맛과 쓴맛을 완화시켜 음용하기 적합하다.The beet juice beverage converts the polymer compound into a low molecular weight compound through a low temperature aging process, and the red color characteristic of the beet does not come out from the stool after drinking, so the digestive absorption rate of the intestine is excellent and the fishy smell can be removed through the beating process. It is mixed with carrot juice, apple juice and lemon juice to reduce fishy and bitter taste and is suitable for drinking.
또한, 본 발명은 껍질을 벗겨서 구운 비트 착즙 저온 숙성액 및 사과즙을 포함하는 장내 소화흡수율이 향상된 비트주스 음료를 제공한다.In addition, the present invention provides a beet juice drink with improved intestinal digestive absorption, including peeled baked beet juice low-temperature aging liquid and apple juice.
이때, 저온 숙성 비트즙 및 사과즙은 3:7의 중량 비율로 배합하는 것이 바람직하다.At this time, the low-temperature ripening beet juice and apple juice is preferably blended in a weight ratio of 3: 7.
상기 비트주스 음료에 있어서, 당근즙 또는 레몬즙 중 어느 하나 이상을 혼합하는 것이 바람직하다.In the beet juice drink, it is preferable to mix any one or more of carrot juice or lemon juice.
이때, 저온 숙성 비트즙, 당근즙 및 사과즙은 2.0 ~ 3.0 : 1.5 ~ 2.5 : 5.0 ~ 6.0의 중량 비율로 배합하는 것이 바람직하고, 2.5 : 2 : 5.5의 중량 비율로 배합하는 것이 더욱 바람직하다.At this time, it is preferable to mix | blend low temperature ripening beet juice, carrot juice, and apple juice by the weight ratio of 2.0-3.0: 1.5-2.5: 5.0-6.0, and it is more preferable to mix | blend in the weight ratio of 2.5: 2: 5.5.
또한, 본 발명은 껍질을 벗겨서 구운 비트 착즙의 저온 숙성한 저온 숙성 비트즙, 당근즙 및 사과즙을 포함하는 항산화용 건강식품을 제공한다.In addition, the present invention provides a healthy food for antioxidant, including low-temperature ripening beet juice, carrot juice and apple juice of peeled and baked beet juice.
상기 항산화용 건강식품에 있어서, 저온 숙성 비트즙, 당근즙 및 사과즙은 2.0 ~ 3.0 : 1.5 ~ 2.5 : 5.0 ~ 6.0의 중량 비율로 배합하는 것이 바람직하고, 2.5 : 2 : 5.5의 중량 비율로 배합하는 것이 더욱 바람직하다.In the antioxidant health food, the low-temperature ripening beet juice, carrot juice and apple juice is preferably blended in a weight ratio of 2.0 to 3.0: 1.5 to 2.5: 5.0 to 6.0, it is formulated in a weight ratio of 2.5: 2: 5.5 More preferred.
이때, 사과즙의 비중이 전체비중의 50% 이하로 배합하게 되면 비트즙의 gel화가 진행되기에 주스가 gel화 됨을 방지하기 위해서 사과즙의 적절 배합비율이 바람직하다. At this time, when the specific gravity of apple juice is blended to 50% or less of the total specific gravity, the proper blending ratio of apple juice is preferable to prevent gelation of the juice because the gelation of beet juice proceeds.
상기 항산화용 건강식품에 있어서, 맛과 향 등의 풍미를 위해 레몬즙을 더 포함하는 것이 바람직하다. In the antioxidant health food, it is preferable to further include lemon juice for flavor and flavor.
상기 건강식품은 건강기능식품 또는 건강보조식품일 수 있다.The health food may be a health functional food or health supplement food.
또한, 본 발명은 껍질을 벗겨서 구운 비트 착즙의 저온 숙성한 저온 숙성 비트즙 및 사과즙을 포함하는 항산화용 건강식품을 제공한다.The present invention also provides an antioxidant health food comprising peeled beet juice, low temperature ripening low temperature ripening beet juice and apple juice.
상기 항산화용 건강식품에 있어서, 저온 숙성 비트즙 및 사과즙은 3:7의 중량 비율로 배합하는 것이 바람직하다.In the antioxidant health food, low-temperature ripening beet juice and apple juice is preferably blended in a weight ratio of 3: 7.
상기 건강식품은 건강기능식품 또는 건강보조식품일 수 있다.The health food may be a health functional food or health supplement food.
또한, 본 발명은 껍질을 벗겨서 구운 비트 착즙의 저온 숙성한 저온 숙성 비트즙, 당근즙 및 사과즙을 포함하는 항고혈압용 건강식품을 제공한다.In addition, the present invention provides a health food for antihypertension, including low-temperature ripening beet juice, carrot juice and apple juice of peeled and baked beet juice.
상기 항고혈압용 건강식품에 있어서, 저온 숙성 비트즙, 당근즙 및 사과즙은 2.0 ~ 3.0 : 1.5 ~ 2.5 : 5.0 ~ 6.0의 중량 비율로 배합하는 것이 바람직하고, 2.5 : 2 : 5.5의 중량 비율로 배합하는 것이 더욱 바람직하다.In the above antihypertensive health food, low temperature ripening beet juice, carrot juice and apple juice are preferably blended in a weight ratio of 2.0 to 3.0: 1.5 to 2.5: 5.0 to 6.0, and blended in a weight ratio of 2.5: 2: 5.5. More preferably.
이때, 사과즙의 비중이 전체비중의 50% 이하로 배합하게 되면 비트즙의 gel화가 진행되기에 주스가 gel화 됨을 방지하기 위해서 사과즙의 적절 배합비율이 바람직하다. At this time, when the specific gravity of apple juice is blended to 50% or less of the total specific gravity, the proper blending ratio of apple juice is preferable to prevent gelation of the juice because the gelation of beet juice proceeds.
상기 항고혈압용 건강식품에 있어서, 맛과 형 등의 풍미를 위해 레몬즙을 더 포함하는 것이 바람직하다. In the antihypertensive health food, it is preferable to further include lemon juice for flavors and flavors.
상기 건강식품은 건강기능식품 또는 건강보조식품일 수 있다.The health food may be a health functional food or health supplement food.
또한, 본 발명은 껍질을 벗겨서 구운 비트 착즙의 저온 숙성한 저온 숙성 비트즙 및 사과즙을 포함하는 항고혈압용 건강식품을 제공한다.In addition, the present invention provides a health food for antihypertension, including low-temperature ripening beet juice and apple juice of the peeled and baked beet juice.
상기 항고혈압용 건강식품에 있어서, 저온 숙성 비트즙 및 사과즙은 3:7의 중량 비율로 배합하는 것이 바람직하다.In the above antihypertensive health food, low temperature ripening beet juice and apple juice are preferably blended in a weight ratio of 3: 7.
상기 건강식품은 건강기능식품 또는 건강보조식품일 수 있다.The health food may be a health functional food or health supplement food.
본 발명의 건강식품은 본 발명에 따른 비트주스를 그대로 첨가하거나 다른 식품 또는 식품 성분과 함께 사용될 수 있고, 통상적인 방법에 따라 적절하게 사용될 수 있다.The health food of the present invention may be used as it is, beet juice according to the present invention as it is or in combination with other food or food ingredients, and may be appropriately used according to a conventional method.
본 발명의 건강식품은 본 발명에 따른 비트주스가 전체 건강식품 조성물 100 중량부 대비 50 내지 99 중량부 포함하여 사용될 수 있다.The health food of the present invention may be used, including beet juice 50 to 99 parts by weight based on 100 parts by weight of the whole health food composition.
본 발명의 건강식품의 종류에는 특별한 제한은 없다. 상기 비트주스를 첨가할 수 있는 식품의 예로는 음료류, 주류, 유가공품류, 육류, 면류, 과자류, 빙과류 등이 있으며, 통상적인 의미에서의 건강식품을 모두 포함한다.There is no particular limitation on the type of health food of the present invention. Examples of foods to which the beet juice may be added include beverages, alcoholic beverages, dairy products, meats, noodles, confectionery, ice cream, and the like, and include all health foods in a general sense.
본 발명의 건강식품은 통상의 음료와 같이 여러 가지 향미제 또는 감미제 등을 포함할 수 있고, 여러 가지 영양제, 비타민, 전해질, 풍미제, 착색제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산음료에 사용되는 탄산화제 등을 함유할 수 있으며, 그 밖에 다양한 과육을 함유할 수 있다. 이러한 성분은 독립적으로 또는 혼합하여 사용할 수 있다. 이러한 첨가제의 비율은 크게 중요하진 않지만 전체 건강식품 조성물 100 중량부 당 0.01 ~ 0.1 중량부의 범위에서 선택되는 것이 일반적이다.The health food of the present invention may include various flavors or sweeteners, such as conventional beverages, and various nutritional agents, vitamins, electrolytes, flavoring agents, coloring agents, pectic acid and salts thereof, alginic acid and salts thereof, organic acids, Protective colloid thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohols, carbonation agents used in carbonated beverages and the like, and may contain a variety of other flesh. These components can be used independently or in combination. The proportion of such additives is not critical, but is usually selected in the range of 0.01 to 0.1 parts by weight per 100 parts by weight of the whole health food composition.
이하, 실시예를 통하여 본 발명을 보다 상세히 설명하기로 한다. 이들 실시예는 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로, 본 발명의 요지에 따라 본 발명의 범위가 이들 실시예에 의해 제한되지 않는다는 것은 당 업계에서 통상의 지식을 가진 자에게 있어서 자명한 것이다.Hereinafter, the present invention will be described in more detail with reference to Examples. These examples are only for illustrating the present invention in more detail, it is apparent to those skilled in the art that the scope of the present invention is not limited by these examples in accordance with the gist of the present invention. .
<실시예 1> 비트주스 제조 1Example 1 Beet juice preparation 1
비트 1 Kg을 깨끗한 물에 세척한 뒤 껍질을 벗기고 200 ℃에서 1분 간 구운 후, 착즙기를 이용하여 착즙하여 비트 착즙액을 얻었다. 이후 5 ℃의 저장고에서 3일 동안 저온 숙성 과정을 거친 후, 당근즙, 사과즙 및 레몬즙을 첨가해 잘 섞어 혼합물을 제조하였다. 이때, 저온 숙성 비트즙 40 중량%, 당근즙 20 중량%, 사과즙 39 중량% 및 레몬즙 1중량% 비율로 혼합하였다.1 Kg of beet was washed with clean water, peeled and baked at 200 ° C. for 1 minute, and then juiced using a juicer to obtain beet juice. After the low-temperature aging process for 3 days in a storage of 5 ℃, carrot juice, apple juice and lemon juice was added to prepare a mixture. At this time, 40% by weight of low-temperature ripening beet juice, 20% by weight carrot juice, 39% by weight apple juice and 1% by weight of lemon juice was mixed.
이렇게 제조한 혼합물을 펄스전기장치(Pulsed Electric Field, PEF)를 이용하여 비가열 저온 멸균하여 완성하였다.The mixture thus prepared was completed by unheated pasteurization using a pulsed electric field (PEF).
<실시예 2> 비트주스 제조 2Example 2 Beet Juice Preparation 2
비트를 250 ℃에서 30초 간 구운 것을 제외하고는 상기 <실시예 1>과 동일하게 제조하였다. It was prepared in the same manner as in <Example 1> except that the beet was baked at 250 ° C. for 30 seconds.
<실시예 3> 비트주스 제조 3Example 3 Beet Juice Preparation 3
비트 착즙액을 10℃의 저장고에서 3일 동안 저온 숙성 과정을 거친 것을 제외하고는 상기 <실시예 1>과 동일하게 제조하였다.Beet juice was prepared in the same manner as in Example 1, except that the beet juice was subjected to low temperature aging for 3 days in a 10 ℃ storage.
<실시예 4> 비트주스 제조 4Example 4 Beet Juice Preparation 4
비트 착즙액 30 중량%, 당근즙 20 중량%, 사과즙 49.5 중량% 및 레몬즙 0.5 중량% 혼합한 것을 제외하고는 상기 <실시예 1>과 동일하게 제조하였다.It was prepared in the same manner as in <Example 1> except that the beet juice was mixed 30% by weight, carrot juice 20% by weight, apple juice 49.5% by weight and lemon juice 0.5% by weight.
<비교예 1> 비트 가열 과정이 없는 제조Comparative Example 1 Manufacturing without Bit Heating Process
비트를 가열하지 않는 것을 제외하고는 상기 <실시예 1>과 동일하게 제조하였다.Except for heating the bit was prepared in the same manner as in <Example 1>.
<비교예 2> 비트 가열 조건이 다른 제조Comparative Example 2 Manufacturing with Different Bit Heating Conditions
비트를 250 ℃에서 2분 간 구운 것을 제외하고는 상기 <실시예 1>과 동일하게 제조하였다.It was prepared in the same manner as in <Example 1> except that the beet was baked at 250 ° C. for 2 minutes.
<비교예 3> 저온 숙성 과정이 없는 제조Comparative Example 3 Preparation without Low Temperature Aging Process
저온 숙성 과정을 거치지 않은 것을 제외하고는 상기 <실시예 1>과 동일하게 제조하였다.Except that the low-temperature aging process was prepared in the same manner as in <Example 1>.
<비교예 4> 숙성 조건이 다른 제조<Comparative Example 4> Manufacturing with different aging conditions
비트 착즙액을 실온(20 ~ 25℃)에서 3일 동안 숙성 과정을 거친 것을 제외하고는 상기 <실시예 1>과 동일하게 제조하였다.Beet juice was prepared in the same manner as in <Example 1> except that the juice was aged for 3 days at room temperature (20 ~ 25 ℃).
<비교예 5> 배합 조건이 다른 제조<Comparative Example 5> Manufacture with different compounding conditions
비트 착즙액 50 중량%, 당근즙 19 중량%, 사과즙 30 중량% 및 레몬즙 1 중량% 혼합한 것을 사용한 것을 제외하고는 상기 <실시예 1>과 동일하게 제조하였다.It was prepared in the same manner as in <Example 1> except that 50% by weight of beet juice, 19% by weight of carrot juice, 30% by weight of apple juice and 1% by weight of lemon juice were used.
<비교예 6> 배합 조건이 다른 제조<Comparative Example 6> Manufacturing with Different Mixing Conditions
비트 착즙액 15 중량%, 당근즙 25 중량%, 사과즙 55 중량% 및 레몬즙 5 중량% 혼합한 것을 제외하고는 상기 <실시예 1>과 동일하게 제조하였다.It was prepared in the same manner as in <Example 1> except that 15% by weight beet juice, 25% by weight carrot juice, 55% by weight apple juice and 5% by weight lemon juice.
<비교예 7> 멸균 조건이 다른 제조Comparative Example 7 Preparation with Different Sterilization Conditions
고온멸균기를 사용하여 70 ~ 80℃로 멸균한 것을 제외하고는 상기 <실시예 1>과 동일하게 제조하였다. Except that sterilized at 70 ~ 80 ℃ using a high-temperature sterilizer was prepared in the same manner as in <Example 1>.
<실험예 1> 관능검사Experimental Example 1 Sensory Test
상기 실시예 1 내지 4, 및 비교예 1 내지 7에서 각각 제조한 비트 주스의 맛, 향 및 전체적인 기호도를 알아보기 위한 관능검사를 실시하였다. The sensory test was performed to determine the taste, aroma and overall acceptability of the beet juice prepared in Examples 1 to 4 and Comparative Examples 1 to 7, respectively.
관능검사 요원은 성인 남성 20명과 성인 여성 20명을 대상(남여 각각 20대 5명, 30대 5명, 40대 5명, 50대 5명으로 구성)으로 교육과정을 통하여 평가할 특성에 대한 식별력과 특성, 맛에 대한 안정된 판단기준을 확립한 후 관능검사에 임하였다. 관능검사 항목은 맛, 향, 식감 및 전체적인 기호도의 총 4가지를 10점 만점 기준으로 평가하였다. Sensory test personnel consisted of 20 adult males and 20 adult females (5 males, 20 females, 5 females in 30s, 5 females in 40s, and 5 females in 50s). After establishing stable criteria for characteristics and tastes, they went to the sensory test. The sensory evaluation items were evaluated based on a score of 10 out of 4 items in total: taste, aroma, texture, and overall preference.
채점 기준은 다음과 같다.The scoring criteria are as follows.
아주 좋다 : 10점Very good: 10 points
좋다 : 8점Good: 8 points
보통이다 : 6점Normal: 6 points
나쁘다 : 4점Bad: 4 points
아주 나쁘다 : 2점Very bad: 2 points
그 결과를 표 1에 나타내었다.The results are shown in Table 1.
구분division flavor incense 식감Texture 기호도Symbol
실시예 1Example 1 9.29.2 9.59.5 9.09.0 9.39.3
실시예 2Example 2 9.09.0 9.39.3 8.58.5 9.39.3
실시예 3Example 3 9.29.2 9.19.1 8.98.9 9.09.0
실시예 4Example 4 9.29.2 9.59.5 8.38.3 8.98.9
비교예 1Comparative Example 1 5.85.8 4.24.2 6.26.2 5.55.5
비교예 2Comparative Example 2 5.95.9 4.14.1 6.06.0 5.15.1
비교예 3Comparative Example 3 5.15.1 4.44.4 5.85.8 4.84.8
비교예 4Comparative Example 4 5.75.7 4.04.0 6.06.0 4.74.7
비교예 5Comparative Example 5 5.05.0 4.04.0 5.95.9 4.94.9
비교예 6Comparative Example 6 5.25.2 4.04.0 6.06.0 4.94.9
비교예 7Comparative Example 7 5.55.5 4.04.0 6.06.0 5.35.3
맛을 평가해본 결과, <실시예 1 내지 4>에 의해 제조된 비트 주스는 비트 표피를 가열시켜 굽기 때문에 냄새가 많이 제거되고 구수한 향이 나며, 당근즙, 사과즙 및 레몬즙을 적절히 배합되어 풍미가 향상되었고, 비트의 제조과정 동안 적절한 저온 온도를 유지하여 비트 내 효모효소를 사멸시키지 않고 그대로 보존한 비트 주스를 제조할 수 있었다.As a result of evaluating the taste, the beet juice prepared according to Examples 1 to 4 is removed by heating the beet epidermis to remove odors and has a pleasant aroma, and the flavor is improved by properly mixing carrot juice, apple juice and lemon juice. During the manufacturing process of beet, it was possible to prepare the beet juice preserved as it is without killing the yeast enzyme in the beet by maintaining an appropriate low temperature.
반면, <비교예 1>에 의해 제조된 비트 주스는, 비트를 가열하는 단계를 따로 거치지 않아 비트 본연의 비린맛, 신맛이 느껴지고 냄새에 예민한 사람은 흙냄새도 느낄 수 있었고, <비교예 2>와 같이 긴 시간 가열하였을 때는 비트 내 효모효소가 사멸하고 향도 좋지 않은 것을 알 수 있었고, <비교예 3 내지 4>와 같이 숙성 조건을 변경했을 때는 고분자화합물이 남아있어 소화가 잘되지 않아 기호도가 다소 낮은 것으로 나타났다. 또한, <비교예 5 내지 6>과 같이 배합 조건을 달리한 경우에는 비트 특유의 비린맛과 쓴맛이 강하게 느껴졌으며, <비교예 7>에 의해 제조된 비트 주스는 고온에서 멸균시켜 효모효소가 사멸하고 식감도 좋지 않았다.On the other hand, the beet juice prepared by Comparative Example 1 did not go through the step of heating the beet separately, so the person could feel the natural fishy, sour taste and sensitive to the smell. When heated for a long time, it was found that yeast enzyme in the beet was killed and its fragrance was not good. Found to be low. In addition, when the mixing conditions were different as in <Comparative Examples 5 to 6>, the unique fishy bitterness and bitter taste were strongly felt, and the beet juice prepared by <Comparative Example 7> was sterilized at high temperature to kill yeast enzyme. And the texture was not good.
<실험예 2> 소화흡수율 확인 Experimental Example 2 Confirming Digestion Absorption Rate
상기 실시예 1 내지 4, 및 비교예 1 내지 7에서 각각 제조한 비트 주스의 소화흡수 효능을 알아보기 위한 임상실험을 실시하였다.Clinical experiments were conducted to determine the digestive absorption efficacy of the beet juice prepared in Examples 1 to 4 and Comparative Examples 1 to 7, respectively.
유의차를 줄이기 위하여 유사한 성별 및 나이 구성을 위해, 각 실험군 당 30대 성인 남성 2명과 성인 여성 2명을 실험대상(전체 44명)으로 하였다.In order to reduce the significant differences, two adult males in their 30s and two adult females were used as the subjects (44 patients in total) for similar gender and age composition.
각 실험군 당 해당 주스를 1주일 동안 하루에 250 ml 한 컵씩 섭취하였고, 실험 전 3일부터 종료 때까지 또 다른 과일이나 과일 주스를 섭취하지 못하도록 하여 실시하였다. 소화흡수 평가는 1주일 실험동안 변의 상태, 쾌변 및 위의 편안함 정도의 총 3가지를 10점 만점 기준으로 평가하였고, 변의 색깔을 육안으로 관찰하였다. For each experimental group, the juice was taken one cup of 250 ml per day for one week, and was carried out so as not to consume another fruit or fruit juice from three days before the experiment until the end. Digestive absorption was evaluated for a total of three points out of 10 points out of the state of stools, comfort and stomach comfort during the week, and the color of the stool was visually observed.
채점 기준은 다음과 같다.The scoring criteria are as follows.
아주 좋다 : 10점Very good: 10 points
좋다 : 8점Good: 8 points
보통이다 : 6점Normal: 6 points
나쁘다 : 4점Bad: 4 points
아주 나쁘다 : 2점Very bad: 2 points
그 결과를 표 2에 나타내었다.The results are shown in Table 2.
구분division 변의 상태State of stools 변의 색Color of sides 쾌변Pleasure 위의 편안함Comfort above
실시예 1Example 1 8.28.2 일반 변 색과 큰 차이가 없음No big difference from normal discoloration 8.58.5 8.68.6
실시예 2Example 2 8.08.0 8.18.1 8.48.4
실시예 3Example 3 8.08.0 8.28.2 8.58.5
실시예 4Example 4 8.18.1 8.48.4 8.38.3
비교예 1Comparative Example 1 6.86.8 붉은색 변Red stools 6.16.1 6.56.5
비교예 2Comparative Example 2 6.56.5 5.45.4 5.25.2
비교예 3Comparative Example 3 6.36.3 진한 붉은색 변Dark red stools 5.15.1 5.05.0
비교예 4Comparative Example 4 6.46.4 5.25.2 5.35.3
비교예 5Comparative Example 5 6.66.6 연한 붉은색 변Light red stools 5.75.7 5.65.6
비교예 6Comparative Example 6 6.56.5 5.85.8 5.65.6
비교예 7Comparative Example 7 6.46.4 5.95.9 5.85.8
임상실험 결과, <실시예 1 내지 4>에 의해 제조된 비트 주스를 음용한 경우, 대부분 피험자들의 변의 상태, 쾌변 정도, 위의 편안함 모두 8.0 좋음 이상을 나타내었으며, 변의 색 또한 일반 변 색과 큰 차이가 없는 것으로 나타났다.As a result of clinical experiments, the beet juice prepared according to Examples 1 to 4 showed that the stool state, the degree of pleasure, and the comfort of the subjects showed more than 8.0 good for most of the subjects. No difference was found.
반면, <비교예 1 내지 2>에 의해 제조된 비트 주스를 음용한 경우, 변의 상태가 좋지 않았으며, 쾌변 정도도 보통 수준이었고 위의 편안함 또한 보통이였으며, 변의 색이 붉은색을 띄는 것을 확인하였다. 마찬가지로 <비교예 3 내지 4>의 비트 주스를 음용한 경우 피험자들이 소화불량을 호소하였고 변의 상태, 쾌변 정도, 위의 편안함 모두 좋지 않은 것으로 나타났으며, 변의 색이 비트주스의 진한 붉은색을 많이 띄고 있는 것을 확인하였다.On the other hand, when drinking beet juice prepared in <Comparative Examples 1 to 2>, the stools were not in good condition, the degree of pleasure was normal, the comfort of the stomach was normal, and the color of the stools was red. It was. Likewise, subjects complained of indigestion, stool status, degree of pleasure, and comfort in stomach when drinking beet juice of <Comparative Examples 3 to 4>, and the color of the stool was dark red color of beet juice. It confirmed that it stood out.
또한, <비교예 5 내지 6>의 경우 맛과 식감이 좋지 않아 변의 상태, 쾌변 정도 및 위의 편안함이 좋지 않은 것으로 나타났으며, <비교예 7>의 비트 주스를 음용한 경우도 변의 상태, 쾌변 정도, 위의 편안함 모두 좋지 않으며, <비교예 5 내지 7>을 음용한 피험자들의 변색은 비트주스 연한 붉은색을 띄는 것을 확인하였다. In addition, in Comparative Examples 5 to 6, the taste and texture were not good, so the stool state, the degree of comfort and stomach comfort were not good. Both the degree of comfort and the above comfort were poor, and it was confirmed that the discoloration of the subjects who consumed the Comparative Examples 5 to 7 had a bit juice light red color.
<실험예 3> 총 폴리페놀 함량 분석 Experimental Example 3 Total Polyphenol Content Analysis
<3-1> 시료의 준비<3-1> Preparation of Sample
시료 2(Sample 2; S2)로서, 상기 <실시예 1>과 같은 방법과 같이 저온 숙성 비트즙, 당근즙 및 사과즙을 각각 2.5 : 2 : 5.5의 중량 비율로 혼합하여 장내 흡수율을 개선한 비트주스를 준비하였다.Sample 2 (Sample 2; S2), the low-temperature ripening beet juice, carrot juice and apple juice were mixed in a weight ratio of 2.5: 2: 5.5, respectively, in the same manner as in <Example 1> beet juice improved intestinal absorption Was prepared.
또한, 시료 1(Sample 1; S1)로서, 비트를 그대로 착즙한 비트 원액을 준비하였다.In addition, as sample 1 (Sample 1; S1), a beet stock solution in which the beet was juiced as it was prepared was prepared.
또한, 시료 3(Sample 3; S3)으로서, 상기 시료 2의 비트주스를 증류수로 2배 희석한 비트주스를 준비하였다.As sample 3 (S3), beet juice obtained by diluting the beet juice of sample 2 with distilled water twice was prepared.
<3-2> 총 폴리페놀 함량 측정<3-2> Total Polyphenol Content Measurement
폴리페놀은 식물에서 발견 되는 화학물질로, 플라보노이드, 카테킨 및 탄닌이 주성분으로 항산화, 항암, 항고혈압 등의 효과를 나타내는 것으로 알려져 있는 물질이다.Polyphenols are chemicals found in plants. Flavonoids, catechins, and tannins are known to have antioxidant, anti-cancer, and antihypertensive effects.
총 폴리페놀 함량 측정은 Folin-Deni법을 이용하여 측정하였다. 준비된 1mL의 각 시료 1 ~ 3에 Folin-ciocalteus' phenol reagent 100 μL를 첨가하여 실온에서 5분간 반응 후 Na 2CO 3 용액(7%, w/v) 200 μL와 증류수 700 μL를 넣어 실온에서 1시간 반응시켰다. 반응 후 720 nm에서 흡광도를 측정하였고, gallic acid를 이용하여 작성한 표준검정곡선을 이용하여 추출물의 총 폴리페놀 함량을 나타내었다.Total polyphenol content was measured using the Folin-Deni method. 100 μL of Folin-ciocalteus' phenol reagent was added to each of the prepared 1 mL samples 1 to 3, followed by reaction at room temperature for 5 minutes, followed by 200 μL of Na 2 CO 3 solution (7%, w / v) and 700 μL of distilled water. The reaction was time. After the reaction, the absorbance was measured at 720 nm, and the total polyphenol content of the extract was expressed using a standard calibration curve prepared using gallic acid.
그 결과, 도 2에 나타난 바와 같이, 총 폴리페놀 함량은 시료 2와 시료 3에서 높은 수준으로 함유되어 있음을 확인하였다(도 2).As a result, as shown in Figure 2, it was confirmed that the total polyphenol content is contained at a high level in Samples 2 and 3 (Fig. 2).
<실험예 4> DPPH 라디칼 소거능 분석 Experimental Example 4 Analysis of DPPH Radical Scavenging Capacity
<4-1> 시료의 준비<4-1> Preparation of Sample
상기 실시예 <3-1>와 같이 시료 1(Sample 1; S1), 시료 2(Sample 2; S2) 및 시료 3(Sample 3; S3)을 준비하였다.As in Example <3-1>, Sample 1 (Sample 1; S1), Sample 2 (Sample 2; S2), and Sample 3 (Sample 3; S3) were prepared.
<4-2> DPPH radical scavenging 활성 측정<4-2> Measurement of DPPH radical scavenging activity
DPPH 라디칼 소거활성은 비교적 간단한 항산화 측정법으로, DPPH가 페놀성 화합물 등으로부터 전자 또는 수소를 제공받아 DPPH-H환원되면서 자색이 탈색되는 원리를 이용하여 항산화 활성을 측정하는 방법이다. DPPH radical scavenging activity is a relatively simple method of measuring antioxidant activity. It is a method of measuring antioxidant activity using the principle that DPPH receives an electron or hydrogen from a phenolic compound or the like and is purple when the PHPH is reduced.
DPPH 라디칼 소거 활성 실험은 Blosis 방법을 이용하여 사용하였다. 0.2 mM로 준비된 DPPH와 각 시료를 섞고 실온에서 10분간 방치한 후 ELASA reader SpectraMax ® M3 Multi-Mode Microplate Reader(Molecular Devices, Sunnyvale, CA, USA)를 사용하여 517nm에서 흡광도를 측정하였다. DPPH의 흡광도가 50% 감소 할 때 나타나는 시료의 농도(SC50)로 표시 하였으며, 각 시료는 3회 반복실험을 실시하여 평균값을 구하였다. 이때 사용된 대조군으로는 vitamin C를 사용하였다.DPPH radical scavenging activity experiment was used using the Blosis method. After mixing at room temperature, the sample prepared with 0.2 mM DPPH and each stand for 10 minutes using ELASA reader SpectraMax ® M3 Multi-Mode Microplate Reader (Molecular Devices, Sunnyvale, CA, USA) was measured at 517nm. The absorbance of DPPH was expressed by the concentration of the sample (SC50), which was reduced by 50%. Each sample was repeated three times to obtain an average value. Vitamin C was used as a control.
그 결과, 도 3에 나타난 바와 같이, 시료 2와 시료 3가 우수한 DPPH 라디칼 소거활성을 가지고 있는 것을 확인하였다(도 3).As a result, as shown in FIG. 3, it was confirmed that Sample 2 and Sample 3 had excellent DPPH radical scavenging activity (FIG. 3).
<실험예 5> ABTS radical scavenging 활성 분석 Experimental Example 5 Analysis of ABTS Radical Scavenging Activity
<5-1> 시료의 준비<5-1> Preparation of Sample
상기 실시예 <3-1>와 같이 시료 1(Sample 1; S1), 시료 2(Sample 2; S2) 및 시료 3(Sample 3; S3)을 준비하였다.As in Example <3-1>, Sample 1 (Sample 1; S1), Sample 2 (Sample 2; S2), and Sample 3 (Sample 3; S3) were prepared.
<5-2> ABTS radical scavenging 활성 측정<5-2> Measurement of ABTS radical scavenging activity
ABTS radical 소거활성은 7.4 mM ABTS와 2.6 mM potassium persulfate를 혼합 후 실온 암소에서 15시간 동안 방치하여 radical을 형성시킨 후 이 용액을 734 nm에서 흡광도 값이 0.70±0.02가 되도록 준비하였다. 준비된 ABTS 용액 180μL에 각 시료 20μL를 가하여 실온에서 15분 동안 방치한 다음 734 nm에서 흡광도를 측정하였다. ABTS radical 소거활성은 시료 용액의 첨가군과 무첨가군 사이의 흡광도 차이를 백분율로 나타내었다.ABTS radical scavenging activity was prepared by mixing 7.4 mM ABTS and 2.6 mM potassium persulfate and leaving it in the dark at room temperature for 15 hours to form radicals. The solution was then prepared to have an absorbance of 0.70 ± 0.02 at 734 nm. 20 μL of each sample was added to 180 μL of the prepared ABTS solution, and the mixture was left at room temperature for 15 minutes, and then absorbance was measured at 734 nm. ABTS radical scavenging activity was expressed as a percentage difference in absorbance between the sample solution addition group and the no addition group.
그 결과, 도 4에 나타난 바와 같이, 시료 2와 시료 3가 우수한 ABTS 라디칼 소거활성을 가지고 있는 것을 확인하였다(도 4).As a result, as shown in FIG. 4, it was confirmed that Sample 2 and Sample 3 had excellent ABTS radical scavenging activity (FIG. 4).
<실험예 6> FRAP법에 의한 항산화 활성 분석 Experimental Example 6 Antioxidant Activity Analysis by FRAP Method
<6-1> 시료의 준비<6-1> Preparation of Sample
상기 실시예 <3-1>와 같이 시료 1(Sample 1; S1), 시료 2(Sample 2; S2) 및 시료 3(Sample 3; S3)을 준비하였다.As in Example <3-1>, Sample 1 (Sample 1; S1), Sample 2 (Sample 2; S2), and Sample 3 (Sample 3; S3) were prepared.
<6-2> FRAP법에 의한 항산화 활성 측정 <6-2> Antioxidant Activity by FRAP Method
FRAP법은 낮은 pH에서 ferric tripyridyltriazine (Fe 3 +)가 항산화제에 의하여 ferrous tripyridyltriazine (Fe 2 +)로 환원 시 발생되는 흡광도의 변화를 측정함으로써 항산화 활성을 측정한다. FRAP method measures the antioxidant activity by measuring the change in absorbance generated during reduction is tripyridyltriazine ferric (Fe + 3) at low pH to tripyridyltriazine ferrous (Fe + 2) by an antioxidant.
FRAP(ferric reducing antioxidant power)법에 의한 항산화 활성은 Benzie와 Strain의 방법에 따라 실시하였다. 300 mM acetate buffer (pH 3.6), 10 mM TPTZ (2,4,6-tripyridyl -s-triazine)가 용해된 40 mM HCl 용액과 20 mM FeCl 3·6H 2O를 각각 10:1:1 (v/v/v)의 비율로 혼합하여 FRAP 기질액으로 사용하였다. 96-well plate에 각 시료 40 μL, FRAP 기질액 100 μL와 증류수 200 μL를 차례로 혼합하여 37℃에서 4분간 반응시킨 후 593nm에서 흡광도를 측정하였다. 각 시료는 3회 반복하여 실시하였고, FeSO 4·7H 2O를 표준물질로 하여 얻은 표준검정곡선을 이용하여 분석하였다.Antioxidant activity by FRAP (ferric reducing antioxidant power) method was carried out according to the method of Benzie and Strain. A 40 mM HCl solution containing 300 mM acetate buffer (pH 3.6), 10 mM TPTZ (2,4,6-tripyridyl-s-triazine), and 20 mM FeCl 3 .6H 2 O, respectively, were treated with 10: 1: 1 (v / v / v) and used as a FRAP substrate solution. 40 μL of each sample, 100 μL of FRAP substrate solution, and 200 μL of distilled water were sequentially mixed in a 96-well plate and reacted at 37 ° C. for 4 minutes, and the absorbance was measured at 593 nm. Each sample was repeated three times, and analyzed using a standard calibration curve obtained using FeSO 4 · 7H 2 O as a standard.
그 결과, 도 5에 나타난 바와 같이, 시료 2와 시료 3가 우수한 항산화 활성을 가지고 있는 것을 확인하였다(도 5).As a result, as shown in FIG. 5, it was confirmed that Sample 2 and Sample 3 had excellent antioxidant activity (FIG. 5).
SampleSample Total polyphenol(mg GAE/100mL)Total polyphenol (mg GAE / 100 mL) DPPH(SC 50, %)DPPH (SC 50 ,%) ABTS(SC50, %)ABTS (SC50,%) FRAP(umol Fe2/sample ml)FRAP (umol Fe2 / sample ml)
1One 90.78±7.4690.78 ± 7.46 0.95±0.060.95 ± 0.06 0.2±0.0110.2 ± 0.011 38.88±2.9938.88 ± 2.99
22 30.28±2.5230.28 ± 2.52 2.01±0.152.01 ± 0.15 0.53±0.0340.53 ± 0.034 13.62±1.0613.62 ± 1.06
33 24.66±2.1124.66 ± 2.11 2.51±0.212.51 ± 0.21 0.69±0.0470.69 ± 0.047 10.44±0.9810.44 ± 0.98
<실험예 7> betanin 분석 Experimental Example 7 betanin analysis
<7-1> 시료의 준비<7-1> Preparation of Sample
상기 실시예 <3-1>와 같이 시료 1(Sample 1; S1), 시료 2(Sample 2; S2) 및 시료 3(Sample 3; S3)을 준비하였다.As in Example <3-1>, Sample 1 (Sample 1; S1), Sample 2 (Sample 2; S2), and Sample 3 (Sample 3; S3) were prepared.
<7-2> 베타닌 함량 측정<7-2> Betanin content measurement
베타닌 분석은 Synergi 4 μ POLAR-RP 80A 컬럼(250×4.6 mm, 4 μm Phenomenex)을 장착한 1200 series HPLC (Agilent Technologies, CA, USA)를 사용하였다. 분석 조건은 검출 파장(detection wavelength) 538 nm, 유량 (flow rate) 1.0 mL/min, 컬럼 온도(column temperature) 35℃로 설정하여 분석하였다. 시료는 자동 주입기(automatic injector)를 사용하여 20.0 μL 주입하였다. 이동상 용매는 solvent A [water: formic acid, (99: 1, v/v)]와 solvent B (acetonitrile, CH3CN)를 사용하였다. 용매 농도 구배는 solvent B를 기준으로 실시하였고 총 25분의 분석 시간이 소요되었다. Solvent B는 처음에 0%로 시작하여 15분까지 20%로 증가시킨 후 20분까지 40%로 증가시켰다. 20.1분에 0%로 급격히 감소시킨 후 25분까지 0%를 유지시켰다. 분석된 각 성분은 외부 표준물질인 betanin의 머무름 시간(retention time, RT)이 동일하여 동정하였고, HPLC 피크 면적(area)을 기준으로 각 베타닌 성분의 피크 면적을 비교하여 정량하였다.Betanin analysis was performed using 1200 series HPLC (Agilent Technologies, CA, USA) equipped with Synergi 4 μ POLAR-RP 80A column (250 × 4.6 mm, 4 μm Phenomenex). Analytical conditions were analyzed by setting a detection wavelength of 538 nm, a flow rate of 1.0 mL / min, and a column temperature of 35 ° C. Samples were injected with 20.0 μL using an automatic injector. As a mobile phase solvent, solvent A [water: formic acid, (99: 1, v / v)] and solvent B (acetonitrile, CH3CN) were used. Solvent concentration gradient was performed based on solvent B and took a total of 25 minutes analysis time. Solvent B initially started at 0% and increased to 20% by 15 minutes and then 40% by 20 minutes. It rapidly decreased to 0% at 20.1 minutes and then held at 0% until 25 minutes. The analyzed components were identified by the same retention time (RT) of betanin, an external standard, and quantified by comparing the peak areas of each betaine component based on the HPLC peak area (area).
그 결과, 도 6에 나타난 바와 같이, 시료 2와 시료 3에 betanin 함량이 높은 것을 확인하였다(도 6).As a result, as shown in Figure 6, it was confirmed that the betanin content is high in Samples 2 and 3 (Fig. 6).
<실험예 8> 고혈압 모델동물에서 항고혈압 효능 평가Experimental Example 8 Evaluation of Antihypertensive Effect in Hypertension Model Animals
<8-1> 실험동물의 준비<8-1> Preparation of Experimental Animal
실험동물은 24주령의 암컷 선천성 고혈압쥐(Spontaneously Hypertensive Rat; SHR)를 사용하였다. 실험동물 사육실 환경은 온도 23±2℃, 상대습도 50±10 %이었으며, 명암주기는 12시간 단위(조명시간 08:00-20:00)로 조절되었다. 모든 동물실험은 제주대학교 동물실험 윤리위원회의 승인 하에 수행되었다(승인번호: 2018-0053). Experimental animals used a 24 week old female congenital hypertensive rat (SHR). The environment of experimental animal breeding room was 23 ± 2 ℃ and relative humidity 50 ± 10%, and the contrast period was controlled in 12 hours (lighting time 08: 00-20: 00). All animal experiments were performed with the approval of the Jeju Experimental Ethics Committee of Jeju National University (Approval No .: 2018-0053).
반복 투여시 실험군은 다음과 같았다. The experimental group was as follows when repeated administration.
Group 1: SHR (drinking water, ad libitum)Group 1: SHR (drinking water, ad libitum)
Group 2: SHR + Sample 1 (30 ml/day)Group 2: SHR + Sample 1 (30 ml / day)
Group 3: SHR + Sample 3 (30 ml/day)Group 3: SHR + Sample 3 (30 ml / day)
Group 4: SHR + Sample 2 (30 ml/day)Group 4: SHR + Sample 2 (30 ml / day)
<8-2> 1회 경구 투여 후 혈압변화 측정<8-2> Measurement of Blood Pressure Change After Single Oral Administration
시료 당 SHR 1마리에 대하여 1회 경구투여 후 24시간 혈압의 변화를 관찰하였다. 실험군은 다음과 같았다. The change in blood pressure was observed for 24 hours after oral administration to one SHR per sample. The experimental group was as follows.
Group 1: SHR+ D.W. (0.6 ml/rat, p.o.)Group 1: SHR + D.W. (0.6 ml / rat, p.o.)
Group 2: SHR + Sample 1 (0.6 ml/rat, p.o.)Group 2: SHR + Sample 1 (0.6 ml / rat, p.o.)
Group 3: SHR + Sample 2 (0.6 ml/rat, p.o.)Group 3: SHR + Sample 2 (0.6 ml / rat, p.o.)
Group 4: SHR + betanin (50 mg/kg, p.o.)Group 4: SHR + betanin (50 mg / kg, p.o.)
혈압은 CODA non-invasive blood pressure system (Kent Scientific, Torrington, CT)을 사용하여 측정하였다. 혈압측정 전 실험동물의 꼬리 온도를 32-35℃로 유지하였으며, 안정화를 취한 상태에서 혈압을 측정하였다. SHR의 평균혈압은 177 ~182 mmHg 이었다.Blood pressure was measured using a CODA non-invasive blood pressure system (Kent Scientific, Torrington, CT). Before the blood pressure measurement, the tail temperature of the test animal was maintained at 32-35 ° C., and blood pressure was measured while stabilizing. Mean blood pressure of SHR ranged from 177 to 182 mmHg.
그 결과, 도 7에 나타난 바와 같다(도 7). Sample 2의 경우, 투여 후 4시간까지 점진적인 혈압 하강 효과가 관찰되었으며, 이후 다시 원래의 혈압으로 복귀되었다. 반면, Sample 1 투여 시에는 미비하게 혈압이 상승하는 경향이 나타났고, betanin 투여 시에는 대조군과 차이가 없었다.As a result, it is as shown in FIG. 7 (FIG. 7). In case of Sample 2, a gradual blood pressure lowering effect was observed up to 4 hours after administration, and then returned to the original blood pressure. On the other hand, when the sample 1 was administered, there was a tendency of the blood pressure to be inadequate, and the betanin administration was not different from the control group.
<8-3> 반복 경구 투여 후 혈압변화 측정<8-3> Measurement of blood pressure change after repeated oral administration
실험동물은 Group 1: 대조군(SHR), Group 2: sample 1 투여군(30 ml/day), Group 3: sample 2를 증류수로 2배 희석하여 투여한 군(30 ml/day) 과 Group 4: sample 2 원액 투여군(30 ml/day)으로 분류하였으며, 각 군마다 4마리씩 배치하여 3주간 실험하였다. 시료는 30분 이내에 경구로 투여되었으며, 이후 음수와 사료는 자유 급여하였다. 실험군은 다음과 같았다. The experimental animals were treated with Group 1: control group (SHR), Group 2: sample 1 administration group (30 ml / day), Group 3: sample 2 diluted with distilled water (30 ml / day) and Group 4: sample 2 stock solution (30 ml / day) was divided into four groups of each group was tested for 3 weeks. Samples were administered orally within 30 minutes, after which the drinking and feeding were free. The experimental group was as follows.
Group 1: SHR+ D.W. (0.6 ml/rat, p.o.)Group 1: SHR + D.W. (0.6 ml / rat, p.o.)
Group 2: SHR + Sample 1 (0.6 ml/rat, p.o.)Group 2: SHR + Sample 1 (0.6 ml / rat, p.o.)
Group 3: SHR + Sample 2 (0.6 ml/rat, p.o.)Group 3: SHR + Sample 2 (0.6 ml / rat, p.o.)
Group 4: SHR + betanin (50 mg/kg, p.o.)Group 4: SHR + betanin (50 mg / kg, p.o.)
혈압은 CODA non-invasive blood pressure system (Kent Scientific, Torrington, CT)을 사용하여 측정하였다. 혈압측정 전 실험동물의 꼬리 온도를 32-35℃로 유지하였으며, 안정화를 취한 상태에서 혈압을 측정하였다. Blood pressure was measured using a CODA non-invasive blood pressure system (Kent Scientific, Torrington, CT). Before the blood pressure measurement, the tail temperature of the test animal was maintained at 32-35 ° C., and blood pressure was measured while stabilizing.
그 결과, 도 8에 나타난 바와 같다(도 8). Sample 1 투여군(G1)은 2일 이후 지속적인 혈압의 증가 경향을 나타내었다. sample 2 투여군에서는 sample 2의 투여용량과 비례하여 혈압 강하 효과를 나타내었다(G3, G4). As a result, it is as shown in FIG. 8 (FIG. 8). Sample 1 administration group (G1) showed a tendency of continuous increase in blood pressure after 2 days. The sample 2 administration group showed a blood pressure lowering effect in proportion to the dose of sample 2 (G3, G4).
따라서, 이상의 단회 또는 반복투여의 결과로 볼 때 sample 2의 경우 고혈압개선 효과가 있는 것을 알 수 있다. Therefore, it can be seen from the results of the above single or repeated administration that sample 2 has an effect of improving hypertension.
<8-4> 적출 혈관의 이완 반응성 측정<8-4> Measurement of Relaxation Reactivity of Extracted Veins
혈관의 이완성을 조사하기 위해 흉대동맥을 적출하여 3 - 5 mm의 환상절편(aortic ring)을 만들고 Krebs solution(in mM, NaCl 120, KCl 4.75, Glucose 6.4, NaHCO 3 25, KH 2PO 4 1.2, MgSO 4 1.2, CaCl 2 1.7)으로 채운 organ bath에 현수 하였다. 실험이 진행되는 동안 온도는 37℃, 용액의 pH는 carbogen (95% O 2, 5% CO 2)을 공급해 7.4로 유지시켰다. aortic ring의 resting tension은 1.5 g으로 조정한 후 20분마다 용액을 교체하며 1시간 동안 안정시켰다. 혈관의 수축이완 반응은 고정된 aortic ring의 다른 한쪽을 isometric force-displacement transducer (FT03, Grass, AD instruments, U.S.A.)에 연결시켜 physiograph recorder (PowerLab/400, AD instruments, U.S.A.)로 기록하고, Chart8 program으로 분석하였다. 내피세포 의존성 이완 실험은 내피세포가 건재한 혈관에 10 -6 M의 phenylephrine (PE)를 처리하여 혈관을 전 수축시킨 후 acetylcholine (Ach)을 농도(10 -9 ~ 10 -4 M) 누적 적용하여 이완반응을 관찰하고, pD 2 (-Log EC 50)를 계산하였다. To investigate the relaxation of blood vessels, the thoracic aorta was extracted to create an aortic ring of 3-5 mm and Krebs solution (in mM, NaCl 120, KCl 4.75, Glucose 6.4, NaHCO 3 25, KH 2 PO 4 1.2, MgSO 4 1.2 and CaCl 2 1.7) were suspended in an organ bath. During the experiment, the temperature was maintained at 37 ° C. and the pH of the solution was maintained at 7.4 by feeding carbogen (95% O 2 , 5% CO 2 ). The resting tension of the aortic ring was adjusted to 1.5 g and then stabilized for 1 hour with a solution change every 20 minutes. Vasoconstrictor response is recorded with a physiograph recorder (PowerLab / 400, AD instruments, USA) by connecting the other end of the fixed aortic ring to an isometric force-displacement transducer (FT03, Grass, AD instruments, USA), and the Chart8 program. Analyzed. Endothelial cell-dependent relaxation experiments were performed by treating 10 -6 M of phenylephrine (PE) to endothelial cells, and then contracting the blood vessels before releasing them and applying acetylcholine (Ach) cumulatively (10 -9 to 10 -4 M). The reaction was observed and pD 2 (-Log EC 50 ) was calculated.
그 결과, 표 4 및 도 9에 나타난 바와 같이, 정상 혈압군(SD)의 경우에 비하여 SHR은 Ach에 반응성 즉, 이완효과가 감소되었고, EC50상 군간 유의한 차이는 없었지만 Sample 2 투여 군(G4)의 경우 다른 군에 비하여 혈관 이완효과가 증가하였다(표 4 및 도 9).As a result, as shown in Table 4 and Figure 9, compared with the case of the normal blood pressure group (SD), SHR was less responsive to Ach, that is, the relaxation effect was reduced, there was no significant difference between the groups on the EC50 group, but the sample 2 administration group (G4 ), The vascular relaxation effect was increased compared to the other groups (Table 4 and Figure 9).
GroupGroup EC 50(μM)EC 50 (μM) pD 2 pD 2
SDSD 0.0506 ±0.01410.0506 ± 0.0141 7.3772 ±0.14117.3772 ± 0.1411
G1G1 1.4620 ±1.20391.4620 ± 1.2039 6.4521 ±0.48496.4521 ± 0.4849
G2G2 0.4715 ±0.07400.4715 ± 0.0740 6.3366 ±0.06536.3366 ± 0.0653
G3G3 0.1525 ±0.07580.1525 ± 0.0758 7.2441 ±0.59807.2441 ± 0.5980
G4G4 0.0117 ±0.00230.0117 ± 0.0023 7.9514 ±0.09467.9514 ± 0.0946
<8-5> 장기의 중량변화 측정<8-5> Measurement of weight change of organs
실험 최종일 모든 실험동물을 CO 2 gas로 희생시키고, 복대정맥으로 혈액을 채취한 후 심장, 간, 신장, 뇌 등을 적출하였다. 장기의 중량변화를 보기 위하여 각각의 장기를 적출하여 무게를 측정하고 실험동물의 체중으로 나눈 값을 각각 비교하였다. On the last day of the experiment, all the animals were sacrificed with CO 2 gas, blood was collected from the abdominal vein, and the heart, liver, kidney, and brain were extracted. In order to see the weight change of the organs, each organ was extracted and weighed, and the values divided by the weights of the test animals were compared.
장기무게지표(organ weight index) = 장기무게(organ weight) ÷ 체중(body weight) x 100 (%)Organ weight index = organ weight ÷ body weight x 100 (%)
그 결과, 도 10에 나타난 바와 같이, 시료 투여에 의한 체중변화는 군 간의 차이가 없었다. 체중에 대한 장기 무게는 sample 2 투여군과 대조군 간의 차이가 관찰되지 않았다. 그러나 sample 1 투여군의 경우 우측 및 좌측의 신장 모두 유의한 증가를 보였다(도 10).As a result, as shown in Figure 10, the weight change by the administration of the sample did not differ between groups. The long-term weight to body weight did not show a difference between the sample 2 administration group and the control group. However, in the sample 1 administration group, both the right and left kidneys showed a significant increase (FIG. 10).
<8-6> 혈중 Nitrite 변화 측정<8-6> Measurement of Nitrite Change in Blood
혈청 내 nitrite 농도는 Miranda 등의 방법으로 측정하였다. 혈청에 2배 부피의 에탄올을 가하여 3000 rpm으로 10분간 원심분리 하여 단백질을 제거하였다. 상층액 100 μL에 동량의 vanadium (Ⅲ) chloride를 넣어 nitrate를 nitrite로 변환시켰다. 이후 Griess reagent sulfanilamide와 N- (1-naphthyl) ethylenediamine를 각각 50μL씩 넣고 37℃에서 3시간 동안 반응시킨 후 570 nm에서의 흡광도를 측정하였다.Serum nitrite concentration was measured by Miranda et al. Two volumes of ethanol were added to the serum and centrifuged at 3000 rpm for 10 minutes to remove proteins. 100 μL of the supernatant was added with the same amount of vanadium (III) chloride to convert nitrate to nitrite. Thereafter, 50 μL each of Griess reagent sulfanilamide and N- (1-naphthyl) ethylenediamine were added thereto, and reacted at 37 ° C. for 3 hours, and the absorbance at 570 nm was measured.
그 결과, 도 11에 나타난 바와 같이, 혈중 nitrite 는 sample 2 투여군(G3, G4)에서 용량의존적으로 증가하였으나, sample 1 투여군에서는 대조군과 유의한 차이가 없었다. Nitrite의 혈중농도는 G1, G2, G3, G4에서 각각 11.0 ± 0.7, 11.6 ± 0.6, 39.7 ± 1.6 및 69.2± 0.3 uM이었다(도 11).As a result, as shown in Figure 11, the blood nitrite increased dose-dependently in the sample 2 administration group (G3, G4), there was no significant difference from the control group in the sample 1 administration group. Nitrite blood levels were 11.0 ± 0.7, 11.6 ± 0.6, 39.7 ± 1.6 and 69.2 ± 0.3 uM at G1, G2, G3 and G4, respectively (Figure 11).
<8-7> 지질과산화 지표 측정<8-7> Measurement of Lipid Peroxidation Index
혈청 MDA함량은 EZ-Lipid peroxidation (TBARS) assay kit (DoGenBio, Seoul)를 사용하여 측정하였다. 혈청에 TCA 35 mg을 첨가 후 원심분리를 통해 상등액을 취하였다. 상등액 200 μL에 동량의 지시약을 넣고 65℃ 45분 동안 반응시킨 후 540 nm에서 흡광도를 측정하였다.Serum MDA content was measured using EZ-Lipid peroxidation (TBARS) assay kit (DoGenBio, Seoul). After supernatant was added 35 mg of TCA to the serum by centrifugation. The same amount of indicator was added to 200 μL of the supernatant and reacted at 65 ° C. for 45 minutes, and the absorbance was measured at 540 nm.
그 결과, 도 12에 나타난 바와 같이, 지질산화의 지표인 MDA의 혈중농도는 sample 1 투여군(G1)에서는 대조군과 차이가 없었으나, sample 2 투여의 용량 증가에 따라 유의하게 감소하였다. MDA의 혈중농도는 G1은 9.8 ± 1.8, G2는 8.6 ± 0.7, G3는 5.6 ± 0.3 그리고 G4의 경우 3.8 ± 0.4uM 로 sample 2의 경우 지질과산화에 대한 유의한 보호 효과가 나타났다(도 12).As a result, as shown in Figure 12, the blood concentration of MDA, which is an indicator of lipid oxidation was not different from the control group in the sample 1 administration group (G1), but significantly decreased with increasing dose of sample 2 administration. Blood concentrations of MDA were 9.8 ± 1.8 in G1, 8.6 ± 0.7 in G2, 5.6 ± 0.3 in G3 and 3.8 ± 0.4 uM in G4, which showed a significant protective effect on lipid peroxidation in sample 2 (Figure 12).
결과적으로, Sample 2는 고혈압동물에 경구 투여 시 유의한 혈압 강하효과, 혈중 nitrite의 증가 및 MDA의 감소가 관찰되었으며, 체중과 장기지표(organ index)에는 유의한 변화가 없었으며, 또한 acetylcholine에 대한 혈관 반응성이 개선되었다. As a result, Sample 2 showed significant blood pressure lowering effects, increased blood nitrite, and decreased MDA when administered orally to hypertensive animals. Vascular responsiveness was improved.
반면, Sample 1의 경우에는 고혈압동물에 경구 투여에 의하여 혈압강하 효과는 관찰되지 않았고 오히려 상승하는 경향을 나타내었으며, 신장무게의 증가가 관찰되었다. On the other hand, in the case of Sample 1, the hypotension effect was not observed by oral administration to hypertensive animals, but rather increased, and the kidney weight was increased.
이상의 결과로 볼 때, Sample 1에서는 혈압감소 효과가 관찰되지 않았으나, Sample 2의 경우 혈중 질소 화합물의 증가, 지질과산화의 억제 등의 작용을 통하여 혈관 반응성을 개선시키는 것으로 나타났으며, 이에 따라 본 발명에 따른 비트주스는 우수한 고혈압 개선 효과를 나타낼 수 있음을 알 수 있다.As a result, the blood pressure reduction effect was not observed in Sample 1, but Sample 2 was found to improve vascular reactivity through the action of the increase of blood nitrogen compounds, inhibition of lipid peroxidation, according to the present invention It can be seen that the beat juice can exhibit an excellent effect of improving hypertension.

Claims (14)

  1. 비트를 세척한 후 200 내지 300℃에서 30초 내지 1분간 굽는 제1 단계;A first step of washing the beat and then baking at 200 to 300 ° C. for 30 seconds to 1 minute;
    구운 비트를 착즙하는 제2 단계;A second step of juice the baked beet;
    착즙액을 0 내지 10℃에서 3일 내지 4일간 저온 숙성하는 제3 단계; 및A third step of ripening the juice at 0 to 10 ° C. for 3 to 4 days at low temperature; And
    저온 숙성 비트즙에 당근즙, 사과즙 및 레몬즙을 혼합하는 제4 단계;를 포함하는 비트주스의 제조방법.Method for producing beet juice comprising a; 4th step of mixing carrot juice, apple juice and lemon juice in low temperature ripening beet juice.
  2. 청구항 1에 있어서,The method according to claim 1,
    상기 제1 단계에서 비트는 껍질을 벗긴 것을 특징으로 하는 비트주스의 제조방법.In the first step, the beet peeling method of manufacturing beet juice, characterized in that peeled.
  3. 청구항 1에 있어서,The method according to claim 1,
    상기 제2 단계 착즙은 착즙기를 사용하는 것을 특징으로 하는 비트주스의 제조방법. The second step juice is a method of manufacturing beet juice, characterized in that using the juicer.
  4. 청구항 1에 있어서,The method according to claim 1,
    상기 제4 단계에서 비트즙, 당근즙, 사과즙 및 레몬즙은 20 내지 40 중량부, 10 내지 20 중량부, 30 내지 50 중량부, 0.5 내지 1 중량부로 혼합하는 것을 특징으로 하는 비트주스의 제조방법. Beet juice, carrot juice, apple juice and lemon juice in the fourth step is 20 to 40 parts by weight, 10 to 20 parts by weight, 30 to 50 parts by weight, 0.5 to 1 parts by weight of the manufacturing method of beet juice .
  5. 청구항 1에 있어서,The method according to claim 1,
    상기 제4 단계의 당근즙, 사과즙 및 레몬즙은 당근 또는 사과 또는 레몬을 세척한 후 착즙한 것을 포함하는 비트주스의 제조방법.Carrot juice, apple juice and lemon juice of the fourth step is a method of producing beet juice comprising the juice after washing the carrot or apple or lemon.
  6. 청구항 1에 있어서,The method according to claim 1,
    상기 제4 단계를 통해 제조된 혼합액에 멸균 및 포장하는 단계를 더 포함하는 것을 특징으로 하는 비트주스의 제조방법.Method for producing beet juice, characterized in that further comprising the step of sterilization and packaging in the mixed solution prepared through the fourth step.
  7. 청구항 6에 있어서,The method according to claim 6,
    상기 멸균은 펄스전기장치(Pulsed Electric Field, PEF)에서 비가열 저온 멸균하는 것을 특징으로 하는 비트주스의 제조방법.The sterilization method of the beet juice, characterized in that the non-heated pasteurization in a pulsed electric field (Pulsed Electric Field, PEF).
  8. 껍질을 벗겨서 200 내지 300℃에서 30초 내지 1분간 구운 비트를 착즙하여 얻은 착즙액을 0 내지 10℃에서 3일 내지 4일간 저온 숙성한 저온 숙성 비트즙;Peeled beet juice obtained by peeling the peeled juice of the roasted beet at 200 to 300 ° C. for 30 seconds to 1 minute at low temperature at 0 to 10 ° C. for 3 to 4 days;
    당근즙; Carrot juice;
    사과즙; 및 Apple juice; And
    레몬즙을 포함하는, 장내 소화흡수율이 향상된 비트주스 음료.Beet juice drink with improved intestinal digestive absorption, including lemon juice.
  9. 껍질을 벗겨서 구운 비트 착즙의 저온 숙성한 저온 숙성 비트즙, 당근즙 및 사과즙을 포함하는 항산화용 건강식품.Healthy food for antioxidants comprising low temperature ripening low temperature ripening beet juice, carrot juice and apple juice of peeled and baked beet juice.
  10. 청구항 9에 있어서,The method according to claim 9,
    상기 저온 숙성 비트즙은 비트의 껍질을 벗겨서 200 내지 300℃에서 30초 내지 1분간 구운 후, 구운 비트를 착즙한 다음, 착즙액을 0 내지 10℃에서 3일 내지 4일간 저온 숙성하여 제조된 것을 특징으로 하는 항산화용 건강식품. The low temperature ripening beet juice was peeled and baked at 200 to 300 ℃ for 30 seconds to 1 minute, then the baked beet juice, then the juice was prepared by low temperature ripening at 0 to 10 ℃ for 3 to 4 days Health foods for antioxidants.
  11. 청구항 9에 있어서,The method according to claim 9,
    상기 저온 숙성 비트즙, 당근즙 및 사과즙은 2.0 ~ 3.0 : 1.5 ~ 2.5 : 5.0 ~ 6.0의 중량 비율로 배합하는 것을 특징으로 하는 항산화용 건강식품. The low temperature ripening beet juice, carrot juice and apple juice is an antioxidant health food, characterized in that blended in a weight ratio of 2.0 to 3.0: 1.5 to 2.5: 5.0 to 6.0.
  12. 껍질을 벗겨서 구운 비트 착즙의 저온 숙성한 저온 숙성 비트즙, 당근즙 및 사과즙을 포함하는 항고혈압용 건강식품.Healthy food for antihypertension, including low temperature ripening low temperature ripening beet juice, carrot juice and apple juice of peeled and baked beet juice.
  13. 청구항 12에 있어서,The method according to claim 12,
    상기 저온 숙성 비트즙은 비트의 껍질을 벗겨서 200 내지 300℃에서 30초 내지 1분간 구운 후, 구운 비트를 착즙한 다음, 착즙액을 0 내지 10℃에서 3일 내지 4일간 저온 숙성하여 제조된 것을 특징으로 하는 항고혈압용 건강식품.The low temperature ripening beet juice was peeled and baked at 200 to 300 ℃ for 30 seconds to 1 minute, and then the baked beet juice, then the juice was prepared by low temperature aging for 3 to 4 days at 0 to 10 ℃ Health foods for antihypertensive.
  14. 청구항 12에 있어서,The method according to claim 12,
    상기 저온 숙성 비트즙, 당근즙 및 사과즙은 2.0 ~ 3.0 : 1.5 ~ 2.5 : 5.0 ~ 6.0의 중량 비율로 배합하는 것을 특징으로 하는 항고혈압용 건강식품.The low temperature ripening beet juice, carrot juice and apple juice is an antihypertensive health food, characterized in that blended in a weight ratio of 2.0 to 3.0: 1.5 to 2.5: 5.0 to 6.0.
PCT/KR2019/007692 2018-07-02 2019-06-26 Beet juice having increased intestinal absorption rate, preparation method therefor and use thereof WO2020009362A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CN201980003054.4A CN110876258B (en) 2018-07-02 2019-06-26 Beetroot juice for improving intestinal absorption rate, its preparation method and application
JP2019570850A JP6902806B2 (en) 2018-07-02 2019-06-26 Beet juice with enhanced intestinal absorption rate and its manufacturing method and applications
US16/626,361 US11324245B2 (en) 2018-07-02 2019-06-26 Beet juice with increased intestinal absorption, its manufacturing method and its use
GB1918635.2A GB2578035B (en) 2018-07-02 2019-06-26 Beet juice with increased intestinal absorption, its manufacturing method and its use

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR20180076724 2018-07-02
KR10-2018-0076724 2018-07-02
KR10-2019-0044885 2019-04-17
KR1020190044885A KR102134700B1 (en) 2018-07-02 2019-04-17 Beet juice with increased intestinal absorption, its manufacturing method and its use

Publications (1)

Publication Number Publication Date
WO2020009362A1 true WO2020009362A1 (en) 2020-01-09

Family

ID=69059320

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2019/007692 WO2020009362A1 (en) 2018-07-02 2019-06-26 Beet juice having increased intestinal absorption rate, preparation method therefor and use thereof

Country Status (1)

Country Link
WO (1) WO2020009362A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000016830A (en) * 1998-08-28 2000-03-25 변유량 Non-thermal Sterilization of Beberages by High Voltage Pulsed Electric Fields
JP2007306904A (en) * 2006-05-17 2007-11-29 Shiro Yamashita Method for producing baked fruit vegetable juice
KR20130048958A (en) * 2011-11-03 2013-05-13 박지원 Method for manufacturing juice having antioxidant function and juice having antioxidant function
KR101293072B1 (en) * 2012-10-12 2013-08-05 김대석 Manufacturing method for kohlrabi juice using the electrolysis disinfection
KR20130118567A (en) * 2012-04-20 2013-10-30 서영호 Good fruit and vegetable extracts rhinitis method of manufacture

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000016830A (en) * 1998-08-28 2000-03-25 변유량 Non-thermal Sterilization of Beberages by High Voltage Pulsed Electric Fields
JP2007306904A (en) * 2006-05-17 2007-11-29 Shiro Yamashita Method for producing baked fruit vegetable juice
KR20130048958A (en) * 2011-11-03 2013-05-13 박지원 Method for manufacturing juice having antioxidant function and juice having antioxidant function
KR20130118567A (en) * 2012-04-20 2013-10-30 서영호 Good fruit and vegetable extracts rhinitis method of manufacture
KR101293072B1 (en) * 2012-10-12 2013-08-05 김대석 Manufacturing method for kohlrabi juice using the electrolysis disinfection

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"Making Detox Juice with Beet Juice", EFFECTS OF BEET NAVER BLOG, 28 March 2019 (2019-03-28), pages 1 - 10, Retrieved from the Internet <URL:http://blog.naver.com/kcm5apw/221239669637> *
HOBBS, D. A. ET AL.: "Blood pressure-lowering effects of beetroot juice and novel beetroot-enriched bread products in normotensive male subjects", BRITISH JOURNAL OF NUTRITION, vol. 108, no. 11, 2012, pages 2066 - 2074, XP055669052 *

Similar Documents

Publication Publication Date Title
WO2017030410A1 (en) Composition for prevention or treatment of metabolic syndrome or for antioxidation containing black bean leaf extracts and flavonol glycosides isolated therefrom as active ingredients
WO2016013709A9 (en) Composition for improving skin, containing pomegranate concentrate as active ingredient
WO2020009288A1 (en) Beet juice having increased intestinal uptake and preparation method therefor
WO2010087577A2 (en) Use of thymus capitatus extract, satureja hortensis extract, or carvacrol for treating metabolic diseases
WO2020071667A1 (en) Composition comprising molokhia extract as active ingredient for improving gut microbiome or for alleviating, preventing, or treating intestinal inflammation, leaky gut syndrome, obesity, or metabolic disease
WO2012067316A1 (en) Composition for prevention or treatment of metabolic diseases or complications thereof containing pterocarpan-based compounds or pharmaceutically acceptable salts thereof as active ingredient, or composition for antioxidation
WO2020009362A1 (en) Beet juice having increased intestinal absorption rate, preparation method therefor and use thereof
WO2022005201A1 (en) Composition for preventing, ameliorating, or treating diseases caused by nitration of tyrosine in protein, containing tyrosine as active ingredient
WO2023113107A1 (en) Beverage preparation method using starch-containing crop
WO2010090498A2 (en) Pharmaceutical composition and health food composition containing youngia denticulata extract, fraction thereof, or compound isolated therefrom as active ingredient for improving liver function
EP3062807A1 (en) Compositions comprising a viola herba extract, or an extract of viola herba, persicae semen, cinnamomi ramulus, and glycyrrhiza spp. for the prevention or treatment of lipid-related cardiovascular diseases and obesity
WO2012115469A2 (en) Anti-inflammatory functional food composition for oral administration, and method for preparing the functional food composition
WO2016099146A1 (en) Modified taurine, and pharmaceutical composition for preventing or treating metabolic diseases containing same
WO2015002430A1 (en) Pharmaceutical composition for preventing or treating asthma comprising pistacia weinmannifolia j. poiss. ex franch extract or fraction thereof
WO2021045522A1 (en) Method for producing boiled-down garlic sauce, and boiled-down garlic sauce produced thereby
WO2012138146A9 (en) Composition containing heat-treated powder or extract of glycine soja as active gradient for prevention and treatment of diabetes mellitus and diabetic complications
WO2015046743A1 (en) Pharmaceutical composition for preventing or treating thyroid diseases, containing lonicera caerulea l. var. edulis fruit extract as active ingredient
WO2021002642A1 (en) Composition for preventing or treating rheumatoid arthritis, comprising snake venom
WO2019039810A1 (en) Composition comprising extract of lonicera coerulea for prevention or treatment of pain
WO2016048085A1 (en) Bean-derived extract having increased contents of active ingredients
WO2011078479A2 (en) A composition comprising the extract of prunella vulgaris l. for preventing and treating adhd disease and the use thereof
WO2022092461A1 (en) Pharmaceutical composition for preventing or treating obesity or diabetes, and preparation method therefor
WO2020184879A1 (en) Catechin enzyme-treated material having increased gallic acid, epicatechin and epigallocatechin contents, and method for preparing same
WO2022250348A1 (en) Skin whitening use of cysteine derivative
WO2023128636A1 (en) Composition containing brier tree root extract for alleviation, prevention, or treatment of obesity and metabolic diseases

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref document number: 2019570850

Country of ref document: JP

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 201918635

Country of ref document: GB

Kind code of ref document: A

Free format text: PCT FILING DATE = 20190626

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19830568

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19830568

Country of ref document: EP

Kind code of ref document: A1